US Pat. No. 9,213,313

SYNTHETIC OPTICAL HOLOGRAPHY

The Board of Trustees of ...

1. A method for imaging at least one of a phase and an amplitude characterizing a scattered field emanating from a sample,
the method comprising:
a. sequentially scanning a parameter characterizing the sample to a plurality of successive loci of a hologram dimension;
b. illuminating the sample with a focusing illuminating beam;
c. imposing a specified phase function on a reference beam relative to the illuminating beam;
d. superimposing with the reference beam a field associated with the scattered field;
e. detecting the superimposed reference beam and field associated with the scattered field for each locus to produce a detected
signal;

f. recording the detected signal as a function of locus in order to obtain a hologram; and
g. processing the hologram to generate an image of at least one of phase and amplitude associated with the scattered field.

US Pat. No. 9,176,065

NANOSCALE ARRAY STRUCTURES SUITABLE FOR SURFACE ENHANCED RAMAN SCATTERING AND METHODS RELATED THERETO

Lawrence Livermore Nation...

1. A structure comprising:
a planar substrate;
an array of nanopillars on the planar substrate, the array of nanopillars substantially perpendicular to the planar substrate
and having a substantially cylindrical shape;

a metal drop comprising a first metal and a second metal, the metal drop having a substantially spherical shape, the second
metal of the metal drop uniformly covering the first metal of the metal drop on each nanopillar of the array of nanopillars,
wherein

the second metal further covers a surface of the planar substrate with a layer having a uniform thickness; and
a dielectric material covering and filling a region between adjacent metal drops and between adjacent nanopillars.

US Pat. No. 9,117,940

OPTICAL SYSTEMS FABRICATED BY PRINTING-BASED ASSEMBLY

The Board of Trustees of ...

20. An optical system comprising:
a device substrate;
a plurality of device components supported by the device substrate, wherein each device component comprises a printable micro-solar
cell; and

an array of optical components comprising an array of collecting optical lens to concentrate light on the micro-solar cells,
wherein each member of the array of optical components is optically addressed to a unique member of the plurality of device
components;

wherein each collecting optical lens has a collector area and each micro-solar cell has a solar cell area, and a ratio of
the collector area to the solar cell area is greater than or equal to 400.

US Pat. No. 9,471,967

RELIGHTING FRAGMENTS FOR INSERTION INTO CONTENT

The Board of Trustees of ...

1. A method comprising:
obtaining a fragment model for a fragment;
obtaining a target scene model for a target scene;
generating, based on the fragment model, a set of multiple detail maps for the fragment;
inserting the fragment model into the target scene model;
rendering the target scene model with the inserted fragment model to generate a rendered scene;
generating a composited target scene; and
generating a modified target scene by combining the composited target scene and the set of multiple detail maps.

US Pat. No. 9,403,843

CYSTEINE PROTEASE INHIBITORS AND USES THEREOF

THE TRUSTEES OF COLUMBIA ...

1. A compound of formula (I-a),

wherein,
R1 is —CO2H or —CO2(C1-C4)-alkyl;

R2 is hydrogen or —(C1-C4)-alkyl;

R4 is —(CH2)-thiazolyl;

R5 is —(C1-C6)-alkyl-R6, —(C2-C5)-alkenyl, —(C2-C5)-alkynyl, —(CH2)n-aryl, or —(CH2)n-heteroaryl, wherein said aryl or heteroaryl are substituted with one or more R7 groups;

R6 is —N(R10)C(O)R8 or —N(R10)S(O)2R8;

R7 is independently halogen, —(C1-C3)-alkyl, aryl, methylenedioxyphenyl, —S(O)2N(R10)2, or —S(O)2N(R10)2, wherein said aryl is optionally substituted with one or more R9 groups;

R8 is —(C1-C6)-alkyl-R11 or aryl, wherein aryl is optionally substituted with one or more R9 groups;

R9 is independently hydrogen, halogen, —(C1-C4)-alkyl, —(C1-C4)-haloalkyl, —(C2-C4)-alkynyl, CN, NO2, —S(O)2N(R10)2, or


R10 is independently hydrogen or —(C1-C4)-alkyl;

R11 is hydrogen or


n is an integer from 0-4; and
p is an integer from 0-3.

US Pat. No. 9,186,417

POLYPHOSPHATE-FUNCTIONALIZED INORGANIC NANOPARTICLES AS HEMOSTATIC COMPOSITIONS AND METHODS OF USE

The Regents of the Univer...

1. A hemostatic composition comprising a hemostatically effective amount of a hemostatic agent comprising:
a silica nanoparticle; and
a polyphosphate polymer attached to the silica nanoparticle.

US Pat. No. 9,554,484

APPENDAGE MOUNTABLE ELECTRONIC DEVICES CONFORMABLE TO SURFACES

The Board of Trustees of ...

1. An appendage mountable electronic system, said system comprising:
a flexible or stretchable substrate having an inner surface and an outer surface, wherein the inner surface defines an enclosure
capable of receiving an appendage having a curved surface; and

a flexible or stretchable electronic device comprising one or more sensors, actuators or both supported by the inner surface
or the outer surface of said flexible or stretchable substrate; said sensors, actuators or both comprising one or more inorganic
semiconductor components, one or more metallic components, or one or more inorganic semiconductor components and one or more
metallic components; wherein at least a portion of said inorganic semiconductor components, metallic components or both has
a thickness less than or equal to 500 microns;

wherein said flexible or stretchable substrate and said electronic device provide a net bending stiffness of the system low
enough such that the inner surface of the substrate is capable of establishing conformal contact with a surface of said appendage
provided within said enclosure.

US Pat. No. 9,108,943

PHOTOREACTIVE BENZAMIDE PROBES FOR HISTONE DEACETYLASE 2

THE BOARD OF TRUSTEES OF ...

1. A compound of formula (I):

or a salt, hydrate or solvate thereof, wherein:
X is selected from the group consisting of azido, phenyl and thiophenyl;
each Y is independently selected from the group consisting of hydrogen, alkyl and substituted alkyl; and
R1, R2 and R3 are independently selected from the group consisting of hydrogen, azido, azidoalkyl, azidoalkoxy, and azidoalkylamidyl, wherein
at least one of R1, R2 and R3 is selected from the group consisting of azido, azidoalkyl, azidoalkoxy, and azidoalkylamidyl.

US Pat. No. 9,394,503

SEPARATION PROCESS OF OIL AND SUGARS FROM BIOMASS

The Board of Trustees of ...

1. A method of recovering oil and sugars from a modified plant comprising stems and leaves, wherein the stems and leaves each
contain oil selected from lipids, in an amount from 0.1 to 25 wt % on a dry matter basis and sugars selected from sucrose,
glucose, fructose, other mono, di, or tri saccharides, or mixtures thereof in an amount from 0.1 to 55 wt % on a dry matter
basis,
the method comprising:
mechanically treating the plant to release liquid comprising the oil and sugars from the stems and leaves, thereby forming
a mechanically treated mixture comprising the liquid and solid components, the mechanical treatment being selected from at
least one of shredding, crushing and pressing;

separating the oil from the liquid, thereby forming an oil-rich stream, the oil separation step being selected from centrifugation,
membrane filtration, or solvent extraction; and

separating the sugars from the liquid, thereby forming a sugar-rich solution, the sugar separation step being selected from
centrifugation or membrane filtration.

US Pat. No. 9,224,532

ROLLED-UP INDUCTOR STRUCTURE FOR A RADIOFREQUENCY INTEGRATED CIRCUIT (RFIC)

The Board of Trustees of ...

1. A rolled-up inductor structure for a radiofrequency integrated circuit (RFIC), the rolled-up structure comprising:
a multilayer sheet in a rolled configuration comprising multiple turns about a longitudinal axis, the multilayer sheet comprising
a conductive pattern layer on a strain-relieved layer,

wherein the conductive pattern layer comprises:
at least one conductive strip having a length extending in a rolling direction, the at least one conductive strip thereby
wrapping around the longitudinal axis in the rolled configuration; and

two conductive feed lines connected to the at least one conductive strip for passage of electrical current therethrough, wherein
the two conductive feed lines extend away from the at least one conductive strip in a rolling direction, and

wherein the conductive strip is an inductor cell of the rolled-up inductor structure.

US Pat. No. 9,447,895

MICROFLUIDIC PRESSURE AMPLIFIER CIRCUITS AND ELECTROSTATIC GATES FOR PNEUMATIC MICROSYSTEMS

The Board of Trustees of ...

1. A pneumatic valve system comprising:
a fluidic control line having an inlet, an outlet, a pneumatic valve portion, and a gate chamber portion in fluid communication;
a pressure source in fluid communication with the inlet;
an electrostatic gate comprising a first electrode and a second electrode, wherein the gate chamber portion of the fluidic
control line is sandwiched between the first electrode and the second electrode;

a pressure-balancing chamber having a common inlet and outlet, in continuous communication with the fluidic control line through
a channel; and the first electrode is located between the pressure-balancing chamber and the gate chamber portion;

a fluidic channel fluidly separate from the fluidic control line, the pneumatic valve portion of the fluidic control line
being positioned relative to a portion of the fluidic channel such that expansion of a portion of the fluidic control line
restricts fluid flow through the fluidic channel

wherein the gate chamber is in a normally-open position when a voltage is not applied to the first and the second electrodes.

US Pat. No. 9,349,900

RELEASE STRATEGIES FOR MAKING TRANSFERABLE SEMICONDUCTOR STRUCTURES, DEVICES AND DEVICE COMPONENTS

The Board of Trustees of ...

1. A method of making transferable semiconductor structures, said method comprising the steps of:
providing a multilayer structure comprising a plurality of functional layers and a plurality of release layers; wherein said
release layers are positioned between functional layers in said multilayer structure, and at least one functional layer comprises
a plurality of semiconductor structures anchored to said multilayer structure by a heterogeneous anchor, a homogeneous anchor,
or a heterogeneous and a homogeneous anchor; and

releasing at least a portion of said semiconductor structures from said multilayer structure by separating one or more of
said release layers from one or more of said functional layer and separating said plurality of semiconductor structures from
said anchors, thereby generating said transferable semiconductor structures.

US Pat. No. 9,045,657

VISCOELASTIC INK FOR DIRECT WRITING OF HYDROGEL STRUCTURES

The Board of Trustees of ...

1. A viscoelastic ink for direct writing of hydrogel structures, the ink comprising:
a polymer;
a photopolymerizable moiety;
a photoinitiator; and
water,
wherein the polymer comprises poly(hyaluronic acid) (pHA), methacrylated hyaluronic acid or a blend of the two and is present
at a concentration of about 5 wt. % or greater in the ink.

US Pat. No. 9,486,610

IMPLANTER DEVICE FOR NERVE STIMULATION AND METHOD OF USING THE SAME

THE BOARD OF TRUSTEES OF ...

1. An implanter for peripheral nerve stimulation, the implanter comprising:
a first preformed stylet having a tapered tip and a second preformed stylet having a blunt tip, each of the first and the
second preformed stylets including a butt end that defines a longitudinal axis, its respective tip opposite the butt end,
and a curved portion extending therebetween, each of the first and the second preformed stylets defining a stylet length,
and the curved portion of each of the first and the second preformed stylets extending along the entire stylet length; and

a hollow needle including a first end, a second end opposite the first end, and a curved portion extending therebetween, the
needle being configured to receive each of the first and the second preformed stylets, the needle defining a needle length,
and the curved portion of the needle extending along the entire needle length;

wherein a chord line drawn between the butt end and the tip defines an acute angle with respect to the longitudinal axis,
the acute angle being about 60 degrees such that each of the first and the second preformed stylets conforms to the natural
curvature of a human body for supraorbital or intraorbital nerve stimulation; and

wherein the curved portion of the needle and the curved portion each of the first and the second preformed stylets are of
substantially congruent shapes such that the first and the second preformed stylets are interchangeably insertable into the
needle, the first preformed stylet being insertable first into the needle such that the tapered tip penetrates skin and facia
and the second preformed stylet being insertable second into the needle such that the blunt tip advances the needle to a target
region.

US Pat. No. 9,450,043

METHODS AND DEVICES FOR FABRICATING AND ASSEMBLING PRINTABLE SEMICONDUCTOR ELEMENTS

THE BOARD OF TRUSTEES OF ...

1. A stretchable semiconductor element comprising:
an elastic substrate having a supporting surface; and
a stretchable semiconductor structure having a curved internal surface, wherein said stretchable semiconductor structure is
a single crystalline semiconductor material, wherein said curved internal surface is continuously bonded to said supporting
surface while said elastic substrate is in an expanded state, wherein said curved internal surface has at least one convex
region and at least one concave region, and wherein said stretchable semiconductor structure comprises a bent structure under
strain resulting from application of a force arising from allowing said elastic substrate to relax from the expanded state.

US Pat. No. 9,389,207

PORTABLE GAS ANALYZER

The Board of Trustees of ...

1. A portable gas analyzer system comprising:
a micro gas chromatograph;
a micro flame ionization detector configured to receive a sample gas from the micro gas chromatograph;
a flame-shaped electrode in the micro flame ionization detector; and
a water electrolyzer configured to provide at least one of oxygen and hydrogen to the micro flame ionization detector.
US Pat. No. 9,372,186

MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION

THE REGENTS OF THE UNIVER...

1. A method for sampling esophageal mucosa in a subject comprising:
(a) deploying a device into the esophagus of the subject, the device comprising a capsule located at the distal end of the
device having an opening and a drag material embedded in the capsule, and a line embedded in the drag material and running
through the opening of the capsule, the line comprising one or more capture agents;

(b) removing the device after a predetermined period of time during which the one or more capture agents was exposed to the
esophageal mucosa of the subject;

(c) collecting one or more diagnostic indicators located in the esophageal mucosa; and
(d) evaluating the one or more diagnostic indicators.

US Pat. No. 9,376,421

COMPOUNDS AND METHODS FOR MYOTONIC DYSTROPHY THERAPY

The Board of Trustees of ...

1. A compound of Formula I:

wherein
n is 0, 1, or 2;
A is a direct bond or —C(?O)NH—;
X1 and X2 are each independently —H, —C(?O)NHCH2CH2N(CH2CH2NH2)2, or a moiety of Formula C1:


wherein R1 and R2 are each independently —H or a moiety of Formula C2:


wherein at least one of X1 and X2 is not —H;

or a salt or solvate thereof.

US Pat. No. 9,109,883

HIGH RESOLUTION LARGE DISPLACEMENT/CRACK SENSOR

The Board of Trustees of ...

1. A structural displacement sensor having only a single arched member comprising:
a single arched member having two ends, each end attached to a fastening member, wherein the fastening members are configured
to attach to a structure;

a first strain gauge attached to the arched member, wherein the first strain gauge is operatively connected to a signal processing
device; and

wherein the arched member and first strain gauge are configured to measure a displacement of the structure based on the amount
of strain detected on the first strain gauge;
wherein the first strain gauge is attached to the crown of the arched member, and wherein the arched member is configured
to de-amplify the strain placed on the first strain gauge;wherein the first strain gauge comprises a fiber Bragg grating; andfurther comprising a second fiber Bragg grating strain gauge, wherein the first fiber Bragg grating strain gauge is attached
to the top of the crown of the arched member, and the second fiber Bragg grating strain gauge is attached to the bottom of
the crown of the arched member, such that analyzing signals from the two fiber Bragg grating strain gauges operates to reduce
the effect of an thermally-induced strains in the two fiber Bragg grating strain gauges.

US Pat. No. 9,412,727

PRINTING TRANSFERABLE COMPONENTS USING MICROSTRUCTURED ELASTOMERIC SURFACES WITH PRESSURE MODULATED REVERSIBLE ADHESION

Semprius, Inc., Durham, ...

1. A method of printing transferable components, the method comprising:
pressing a stamp including an elastomeric post having three-dimensional relief features protruding from a surface of the post
against a transferable component on a donor substrate with a first pressure sufficient to mechanically deform at least a portion
of the relief features and to mechanically deform a region of the post between the relief features such that the relief features
and the region between the relief features contact the component over a first contact area;

retracting the stamp from the donor substrate such that the component is adhered to the stamp;
pressing the stamp including the component adhered thereto against a receiving substrate with a second pressure that is less
than the first pressure such that the post contacts the component over a second contact area that is smaller than the first
contact area; and

retracting the stamp from the receiving substrate such that the component is delaminated from the stamp, thereby printing
the component onto the receiving substrate.

US Pat. No. 9,400,353

SILICON-BASED PHOTONIC CRYSTAL FLUORESCENCE ENHANCEMENT AND LASER LINE SCANNING INSTRUMENT

The Board of Trustees of ...

1. A photonic crystal structure, comprising:
a silicon substrate;
a first dielectric having a first index of refraction, wherein the first dielectric has a first surface facing the silicon
substrate and a second surface opposite the first surface, wherein the second surface has a grating structure formed therein;

a second dielectric having a second index of refraction that is higher than the first index of refraction, wherein the second
dielectric covers at least a portion of the grating structure such that the first and second dielectrics together define a
photonic crystal having an optical resonance; and

a Fabry-Perot optical cavity between the photonic crystal and the silicon substrate, wherein the Fabry-Perot optical cavity
couples to the optical resonance of the photonic crystal.

US Pat. No. 9,353,150

SUBSTITUTED PYRAZINO[1?,2?:1 ,5]PYRROLO[2,3-B]-INDOLE-1,4-DIONES FOR CANCER TREATMENT

Massachusetts Institute o...

1. A compound having the structure of formula I-a:

or a pharmaceutically acceptable salt thereof, wherein:
is a single bond or a double bond, as valency permits;
R1 is R, —C(O)R, —C(O)N(R)2—S(O)R, —S(O)2R, —S(O)2OR, —C(R)2OR, or —S(O)2N(R)2;

each R is independently hydrogen or a group selected from C1-20 aliphatic, C1-20 heteroalkyl, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-14 membered bicyclic or polycyclic
saturated, partially unsaturated or aryl ring, a 5-6 membered mono cyclic heteroaryl ring having 1-4 heteroatoms independently
selected from nitrogen, oxygen, or sulfur, a 3-7 membered saturated or partially unsaturated heterocyclic ring having 1-3
heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-14 membered bicyclic or polycyclic saturated or partially
unsaturated heterocyclic ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-14 membered
bicyclic or polycyclic heteroaryl ring having 1-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or:

two R groups are optionally taken together with their intervening atoms to form a 3-14 membered, saturated, partially unsaturated,
or aryl ring having, in addition to the intervening atoms, 0-4 heteroatoms independently selected from nitrogen, oxygen, or
sulfur;

R2 is hydrogen, —[C(R)2]q—OR, —[C(R)2]q—N(R)2, —[C(R)2]q—SR, —[C(R)2]q—OSi(R)3, —[C(R)2]q—OC(O)R, —[C(R)2]q—OC(O)OR, —[C(R)2]q—OC(O)N(R)2, —[C(R)2]q—OC(O)N(R)—SO2R or —[C(R)2]q—OP(OR)2;

each q is independently 0, 1, 2, 3, or 4;
R3 is —SO2R or —COCF3;

R4 is absent when is a double bond or is R or halogen;

R5 is absent when is a double bond or is hydrogen or a C1-6 aliphatic group;

each of R6 and R6? is independently R, halogen, —CN, —NO2, —OR, —SR, —N(R)2, —S(O)2R, —S(O)2N(R)2, —S(O)R, —C(O)R, —C(O)OR, —C(O)N(R)2, —C(O)N(R)—OR, —N(R)C(O)OR, —N(R)C(O)N(R)2, —N(R)S(O)2R, or —OSi(R)3; or

R6 and R6? are taken together to form ?O, ?C(R)2 or ?NR;

n is 0, 1, 2, 3, or 4;
each R7 is independently R, halogen, —CN, —NO2, —OR, —OSi(R)3, —SR, —N(R)2, —S(O)2R, —S(O)2OR, —S(O)2N(R)2, —S(O)R, —C(O)R, —C(O)OR, —C(O)N(R)2, —C(O)N(R)—OR, —N(R)C(O)OR, —N(R)C(O)N(R)2, —N(R)S(O)2R, —P(R)2, —P(OR)2, —P(O)(R)2, —P(O)(OR)2, —P(O)[N(R)2]2—B(R)2, —B(OR)2, or —Si(R)3;

R8 is —(S)m—Rx wherein m is 1, 2, or 3, and Rx is R, —SR, —C(O)R, —C(O)OR, —C(O)N(R)2, —C(S)R, —S(O)R, —S(O)2R, or —S(O)2N(R)2; and

R9 is —(S)p—Ry wherein p is 1, 2, or 3, such that the sum of m and p is 2, 3, or 4, and Ry is R, —SR, —C(O)R, —C(O)OR, —C(O)N(R)2, —C(S)R, —S(O)R, —S(O)2R, or —S(O)2N(R)2; or

R8 and R9 are taken together to form —S—, —(S)m—[C(R)2]q—(S)p—, —(S)m—(S)p—, —(S)m—C(O)—(S)p—, —(S)m—C(S)—(S)p—, —(S)m—S(O)—(S)p—, or —(S)m—S(O)2—(S)p—.

US Pat. No. 9,328,102

SLOW RELEASE OF ORGANOBORONIC ACIDS IN CROSS-COUPLING REACTIONS

The Board of Trustees of ...

1. A method of performing a chemical reaction, comprising:
reacting in a reaction mixture
a compound selected from the group consisting of an organohalide and an organo-pseudohalide, and
a protected organoboronic acid represented by formula (IV):

where
R1 represents an organic group selected from the group consisting of a 2-pyrollyl group, a 2-indolyl group, and a vinyl group,

B represents boron having sp3 hybridization,

R20, R21,R22, R23, and R24 independently are selected from the group consisting of hydrogen and an organic group,

a corresponding unprotected organoboronic acid is unstable by the boronic acid neat stability test, and
the reaction mixture further comprises a base having a pKB of at least 1, and a palladium catalyst; and

forming a cross-coupled product in the reaction mixture.
US Pat. No. 9,388,382

ISOLATION OF CD14 NEGATIVE, CD45 POSITIVE AND CD117 POSITIVE EMBRYONIC-LIKE STEM CELLS FREE OF MONOCYTES FROM HUMAN UMBILICAL CORD BLOOD MONONUCLEAR CELLS

THE BOARD OF TRUSTEES OF ...

1. A method for isolating stem cells, comprising:
(a) providing a sample of human umbilical cord blood;
(b) removing red cells from the sample to obtain mononuclear cells;
(c) culturing the mononuclear cells in a culture medium in a non-tissue culture treated culture vessel having a hydrophobic
surface with a net positive charge for a sufficient time to obtain a cell population negative for CD14 and positive for CD45
and CD 117, which is attached to the culture vessel and essentially free from mesenchymal stem cells and monocytes, wherein
the cell culture does not require a cell feeder;

and optionally further comprising
(d) detaching the cells from the culture vessel by lidocaine EDTA detachment of cells and, optionally, subsequently digestion
with trypsin EDTA.

US Pat. No. 9,382,215

THERAPEUTIC METHODS AND AGENTS FOR TREATING MYOTONIC DYSTROPHY

The Board of Trustees of ...

1. A method for treating myotonic dystrophy comprising administering to a patient in need thereof an effective amount of a
compound of Formula (I):

wherein
m is 0, 1, 2, 3, or 4;
each R1 is independently (C1-C20)alkyl, cycloalkyl, aryl, heteroaryl, heterocycle, halo, hydroxyl, nitro, cyano, alkoxy, carboxy, trifluoromethyl, trifluoromethoxy,
amino, or aminoalkyl; and

each L is independently a divalent alkyl or a divalent radical of the formula —W-A-W— wherein each W is independently —N(R?)C(?O)—,
—C(?O)N(R?)—, —OC(?O)—, —C(?O)O—, —S(O)—, —S(O)2—, —N(R?)—, —C(?O)—, —(CH2)n— where n is 1-10, or a direct bond; wherein each R? is independently H, (C1-C6)alkyl, benzyl, acetyl, or phenacyl; and A is (C1-C20)alkyl, (C2-C16)alkenyl, (C2-C16)alkynyl, (C3-C8)cycloalkyl, (C1-C20)heteroalkyl, (C6-C10)aryl, —(OCH2—CH2)n— where n is 1 to about 20, —C(O)NH(CH2)n, wherein n is 1 to about 6, —N(Me)(CH2)n, wherein n is 1 to about 6; or (C1-C20)alkyl, (C2-C16)alkenyl, (C2-C16)alkynyl, or —(OCH2—CH2)n— interrupted between two carbons, or between a carbon and an oxygen, with a heterocycle, or (C6-C10)aryl group;

or a pharmaceutically acceptable salt thereof;
wherein the administration thereby treats or reduces the symptoms of the myotonic dystrophy.

US Pat. No. 9,415,575

SELF-HEALING LAMINATE SYSTEM

The Board of Trustees of ...

1. A flexible laminate material comprising:
a first flexible multilayered composite comprising a first barrier layer and a first fabric layer,
a second flexible multilayered composite comprising a second barrier layer and a second fabric layer, and
a self-healing composite layer between the first and second flexible multilayered composites, the self-healing composite layer
having a thickness greater than 0.5 ram,

where the self-healing composite layer is able to withstand a strain of more than 10% without delamination and comprises:
an elastomer matrix,
a plurality of first capsules comprising a polymerizer for an elastomer and having an average diameter less than 500 micrometers,
and

a plurality of second capsules comprising a corresponding activator for the polymerizer, and
where the first and second barrier layers may be the same or different, and the first and second fabric layers may be the
same or different,

where the first and second fabric layers are positioned on the top and bottom sides of the laminate material,
and wherein the flexible laminate material further comprises an adhesion promoter between the first barrier layer and the
self-healing composite layer and/or an adhesion promoter between the second barrier layer and the self-healing composite layer.

US Pat. No. 9,399,035

PROCASPASE 3 ACTIVATION BY COMBINATION THERAPY

The Board of Trustees of ...

1. A composition comprising:
(a) about 15 ?M to about 30 ?M of PAC-1:

(b) about 10 ?M to about 15 ?M of tamoxifen; and
(c) a pharmaceutically acceptable diluent, excipient, or carrier.

US Pat. No. 9,086,430

HIGH SENSITIVITY ENVIRONMENTAL SENSOR BOARD AND METHODS FOR STRUCTURAL HEALTH MONITORING

The Board of Trustees of ...

1. A smart sensor circuit board comprising:
an interface to a wireless smart sensor board platform;
a multi-axis accelerometer having a measurement range and resolution set to provide sensitivity to measure ambient structural
vibrations resulting from non-catastrophic routine environmental factors;

an analog to digital converter (ADC) for converting signals from the multi-axis accelerometer, the ADC having a plurality
of individual channels, each channel including oversampling, filtering, and decimation, and each channel being individually
programmable for gain, anti-aliasing, cut-off frequency, sampling, and frequency providing data to said interface; and

a low noise and high sensitivity amplifier having said plurality of individual channels to receive signals from the multi-axis
accelerometer.

US Pat. No. 9,080,981

NANOSCALE ARRAY STRUCTURES SUITABLE FOR SURFACE ENHANCED RAMAN SCATTERING AND METHODS RELATED THERETO

Lawrence Livermore Nation...

1. A method for fabricating a structure, the method comprising:
providing a planar substrate;
coating the planar substrate with a polymer layer;
annealing the polymer layer, wherein the annealing causes a microphase separation of the polymer layer into first portions
and second portions, the first portions being an array of nanostructures surrounded by the second portions, the second portions
being a polymer matrix;

removing the array of nanostructures, whereby the removing forms an array of nanorecesses and the removing exposes portions
of the planar substrate below the removed nanostructures; and

coating a first metal on the polymer matrix and the exposed portions of the planar substrate.

US Pat. No. 9,421,202

PROCASPASE COMBINATION THERAPY FOR GLIOBLASTOMA

The Board of Trustees of ...

1. A composition comprising:
(a) a compound of Formula (I):

(b) the compound PAC-1:
and
(c) a pharmaceutically acceptable diluent, excipient, or carrier;wherein the concentration of the compound of Formula I is about 250 ?M to about 750 ?M and the concentration of PAC-1 is about
5 ?M to about 30 ?M, wherein about means a variation of 20% of the concentration.

US Pat. No. 9,290,756

APPARATUS AND METHODS FOR HIGH THROUGHPUT NETWORK ELECTROPHYSIOLOGY AND CELLULAR ANALYSIS

The Board of Trustees of ...

1. An electrophysiology culture plate, comprising:
a substrate having an upper surface and a lower surface comprising printed circuit board (PCB), the substrate defining a plurality
of open ports in the PCB, each port extending from the upper surface to the lower surface of the substrate;

a plurality of light transmissive optical plates, each optical plate being coupled to the substrate in registration with a
respective port to define a substantially transparent region for the respective port;

a plurality of microelectrodes, wherein each microelectrode is mounted on a top surface of a respective optical plate in the
substantially transparent region;

a plurality of conductive traces, each conductive trace extending from a respective microelectrode mounted on the top surface
of the optical plate to an electrical contact exposed on the lower surface of the substrate, wherein the electrical contact
is configured to interface with external electronics, and wherein the substrate defines a plurality of vias to operatively
receive the plurality of conductive traces;

a plurality of culture wells, wherein each culture well defines an interior cavity and an at least partially open bottom surface,
and wherein each culture well is mounted thereto the top surface of a respective optical plate,

wherein at least one respective microelectrode of the plurality of microelectrodes underlies the at least partially open bottom
surface of a respective culture well and is in communication with the interior cavity of the respective culture well of the
plurality of culture wells.

US Pat. No. 9,272,126

PHOTONIC BIOSENSORS INCORPORATED INTO TUBING, METHODS OF MANUFACTURE AND INSTRUMENTS FOR ANALYZING THE BIOSENSORS

The Board of Trustees of ...

1. A biosensor, comprising:
a tube, and
a photonic sensor in fluid communication with the contents of the tube, wherein the photonic sensor comprises a Surface Enhanced
Raman Spectroscopy (SERS) biosensor comprised of an array of closely-spaced metal nanodomes fabricated on a flexible plastic
film.

US Pat. No. 9,238,597

APPARATUS AND METHODS FOR THE AUTOMATED SYNTHESIS OF SMALL MOLECULES

The Board of Trustees of ...

1. A method of purifying a N-methyliminodiacetic acid (MIDA) boronate from a solution, comprising the steps of
diluting the solution with hexane, thereby selectively precipitating the MIDA boronate; and
isolating the precipitated MIDA boronate.

US Pat. No. 9,139,739

METHOD FOR PREPARING MICRO-PATTERNED SUPERHYDROPHOBIC/SUPERHYDROPHILIC COATINGS

THE BOARD OF TRUSTEES OF ...

1. A method for preparing a hydrophobic coating comprising:
(a) forming a dispersion of a hydrophobic silsesquioxane (HSQ) and a hydrophobic fumed silica (HFS) in an alcohol;
(b) depositing the dispersion onto a surface as a coating; and
(c) drying the coating to evaporate the alcohol,
wherein the HFS/HSQ ratio is greater than 1.0.
US Pat. No. 9,186,418

METHOD OF IDENTIFYING TUMOR ASSOCIATED ANTIGENS

The Board of Trustees of ...

1. A method of identifying one or more tumor associated antigens of a target tumor comprising the steps of:
(a) transfecting genomic or cDNA from cells of a target tumor into recipient cells expressing at least one MHC determinant
that is allogeneic to a plurality of recipient animals;

(b) diluting a suspension of the transfected recipient cells into a plurality of cell pools;
(c) expanding the cells of the plurality of cell pools of step (b);
(d) immunizing each of the recipient animals with a portion of each of the expanded cell pools of step (c);
(e) isolating spleen cells from the recipient animals immunized according to step (d);
(f) incubating the isolated spleen cells with the target tumor cells;
(g) detecting an immune response of the spleen cells to the target tumor cells and identifying the cell pool that generates
the highest level of immune response (the immunohigh pool) and the cell pool that generates the lowest level of immune response (the immunolow pool);

(h) optionally enriching the immunohigh pool by repeating step (b) to step (g) with the immunohigh pool;

(i) isolating RNA from the cells of the immunohigh pool and from control cells;

(j) performing microarray analysis on RNA isolated from the cells of the immunohigh pool and RNA isolated from the control cells; and

(k) identifying one or more genes expressed at increased levels in the cells from the immunohigh pool as compared to the control cells,

wherein the one or more genes identified are tumor associated antigens of the target tumor.

US Pat. No. 9,120,088

HEAVILY DOPED METAL OXIDES AND METHODS FOR MAKING THE SAME

The Board of Trustees of ...

1. A method of making a doped metal oxide, comprising:
heat treating a first doped metal oxide comprising a dopant nonmetal rapid thermal annealing to form a second doped metal
oxide, the heat treating comprising:

heating the first doped metal oxide at a heating rate of from 5°/s to 50°/s to a temperature of from 500° C. to 1,500° C.;
and

maintaining the temperature from 1 minute to 10 minutes; and
after the heat treating, cooling to a temperature of less than 100° C. within 10 minutes;
where the crystal structure of the second doped metal oxide is different from the crystal structure of the first doped metal
oxide.

US Pat. No. 9,106,052

DUAL CHANNEL PUMPING METHOD LASER WITH METAL VAPOR AND NOBLE GAS MEDIUM

The Board of Trustees of ...

1. A laser pumping method, comprising photo pumping a primary amount of energy into a near red satellite band of a metal vapor
and noble gas mixture laser medium to populate an intermediate level near an upper laser level, and pumping a lesser amount
of energy into a highly excited level to stimulate laser output.

US Pat. No. 9,168,225

NANO-HYBRID DELIVERY SYSTEM FOR SEQUENTIAL UTILIZATION OF PASSIVE AND ACTIVE TARGETING

The Board of Trustees of ...

1. A nanohybrid drug delivery composition comprising
a multivalent polymeric scaffold nanocore consisting of branched polyethyleneimine or poly(amidoamine) (PAMAM) dendrimer with
a therapeutic agent and a targeting agent covalently attached thereto; and

an outer shell encapsulating the polymeric scaffold nanocore, the therapeutic agent and the targeting agent, wherein the shell
consists of poly-(lactic acid-co-glycolic acid), polyethylene glycol-b-polylactide-co-glycolide, polyethylene glycol-b-poly-L-lactic
acid, or a unilamellar liposome consisting of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-mPEG-2000, 1,2-dioleoyl-sn-glycero-3-phosphocholine,
1,2-dioleoyl-sn-glycero-3-phospho-(1?-rac-glycerol) and cholesterol.

US Pat. No. 9,300,107

BRIGHT FEW-CYCLE FIBER SOURCE USING RESONANT DISPERSIVE WAVE EMISSION IN AN OPTICAL FIBER

The Board of Trustees of ...

1. A method for generating ultrashort optical pulses, the method comprising:
a. coupling pump pulses of an infrared source characterized by a pump wavelength into an optical fiber characterized by a
core diameter and a zero-dispersion wavelength, the pump wavelength exceeding the zero-dispersion wavelength of the optical
fiber by at least 100 nm; and

b. generating resonant dispersion wave (RDW) emission in the optical fiber, the RDW emission spectrally isolated from the
pump pulses and characterized by a central wavelength blue-shifted by more than 500 nm relative to the pump wavelength;
wherein the core diameter of the optical fiber exceeds the central wavelength of the RDW by at least a factor of five.

US Pat. No. 9,243,040

STABLE HELICAL IONIC POLYPEPTIDES

The Board of Trustees of ...

5. A polymer comprising the polymer PVBLG-8:
wherein n is about 6 to about 600 and at least one nitrogen of the polymer side chain is a cation;or salt thereof.

US Pat. No. 9,233,960

COMPOUNDS AND ANTI-TUMOR NQO1 SUBSTRATES

The Board of Trustees of ...

1. A compound of the Formula (I):

wherein
R1 is alkyl;

R3 is H;

R2 and R4 are each independently —X—R;

each X is independently a direct bond or a bridging group, wherein the bridging group is —O—, —S—, —NH—, —C(?O)—, —O—C(?O)—,
—C(?O)—O—, —O—C(?O)—O—, or a linker of the formula —W-A-W—, wherein

each W is independently —N(R?)C(?O)—, —C(?O)N(R)—, —OC(?O)—, —C(?O)O—, —O—, —S—, —S(O)—, —S(O)2—, —N(R?)—, —C(?O)—, —(CH2)n— where n is 1-10, or a direct bond, wherein each R? is independently H, (C1-C6)alkyl, or a nitrogen protecting group; and

each A is independently (C1-C20)alkyl, (C2-C16)alkenyl, (C2-C16)alkynyl, (C3-C8)cycloalkyl, (C6-C10)aryl, —(OCH2—CH2)n— where n is 1 to about 20, —C(O)NH(CH2)n— wherein n is 1 to about 6, —OP(O)(OH)O—, —OP(O)(OH)O(CH2)n— wherein n is 1 to about 6, or (C1-C20)alkyl, (C2-C16)alkenyl, (C2-C16)alkynyl, or —(OCH2—CH2)n— interrupted between two carbons, or between a carbon and an oxygen, with a cycloalkyl, heterocycle, or aryl group;

each R is independently alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl,
(cycloalkyl)alkyl, (heterocycloalkyl)alkyl, (cycloalkyl)heteroalkyl, (heterocycloalkyl)heteroalkyl, aryl, heteroaryl, (aryl)alkyl,
(heteroaryl)alkyl, hydrogen, hydroxy, hydroxyalkyl, alkoxy, (alkoxy)alkyl, alkenyloxy, alkynyloxy, (cycloalkyl)alkoxy, heterocycloalkyloxy,
amino, alkylamino, aminoalkyl, acylamino, arylamino, sulfonylamino, sulfinylamino, —CORx, —COORx, —CONHRx, —NHCORx, —NHCOORx, —NHCONHRx, —N3, —CN, —NC, —NCO, —NO2, —SH, -halo, alkoxycarbonyl, alkylaminocarbonyl, sulfonate, sulfonic acid, alkylsulfonyl, alkylsulfinyl, arylsulfonyl, arylsulfinyl,
aminosulfonyl, RxS(O)Ry—, RxS(O)2Ry—, RxC(O)N(Rx)Ry—, RxSO2N(Rx)Ry—, RxN(Rx)C(O)Ry—, RxN(Rx)SO2Ry—, RxN(Rx)C(O)N(Rx)Ry—, carboxaldehyde, acyl, acyloxy, —OPO3H2, —OPO3Z2 where Z is an inorganic cation, or saccharide; where each Rx is independently H, OH, alkyl or aryl, and each Ry is independently a group W;

wherein any alkyl or aryl can be optionally substituted with one or more hydroxy, amino, cyano, nitro, or halo groups;
or a salt or solvate thereof;
provided that when R1, R2, and R4 are methyl, R3 is not H or methyl.

US Pat. No. 9,156,884

INHIBITORS OF BETA INTEGRIN-G PROTEIN ALPHA SUBUNIT BINDING INTERACTIONS

THE BOARD OF TRUSTEES OF ...

1. A method of inhibiting thrombosis in a subject in need thereof comprising administering to the subject a peptide, or a
conjugate or a micelle comprising the peptide, in an amount effective to inhibit thrombosis, wherein the peptide comprises
an amino acid sequence
Phe Xaa1 Xaa2 Glu Xaa3 Xaa4
wherein Xaa1 is Glu or Gln and Xaa2 is Glu, Lys, Ser, or Ala,

wherein Xaa3 is Lys, Arg, or Gln and Xaa4 Met, Leu, Ala, Ser, or Gln,

wherein the peptide is a 6-mer, 7-mer, 8-mer, 9-mer-10-mer, 11-mer, 12-mer, 13-mer, or 14-mer.

US Pat. No. 9,125,745

APPARATUS AND METHOD FOR AIRWAY PATENCY AND HEAD IMMOBILIZATION

The Board of Trustees of ...

1. A jaw-thrust device comprising:
a base;
a mandible rest adapted to be mounted in a position proximate to a patient's mandible;
an extension apparatus, said extension apparatus being mounted on said base, said extension apparatus supporting said mandible
rest;

said extension apparatus being vertically extendable to move said mandible rest through jaw thrusting motion which biases
the patient's mandible towards a natural movement of extension of the mandible;

side bars, said side bars being mounted to deploy proximate to a patient's head, said deployment adapted to immobilize the
patient's head;

a chin pad;
at least one strap, said at least one strap connecting said chin pad to at least one of said base or said extension apparatus
and said at least one strap being non-extendible, said at least one strap being anchored to said base or said extension apparatus
by at least one anchor adapted to be located at or below a patient's glenoid fossa;

whereby said mandible rest is adapted to receive jaw thrusting pressure caused by said jaw thrusting motion and responsively
cause rotational force on said chin pad, thereby rotating a patient's chin away from a patient's maxilla, causing a patient's
mouth to move to an open position without substantially tilting the patient's head.

US Pat. No. 9,118,713

SYSTEM AND A METHOD FOR AUTOMATICALLY DETECTING SECURITY VULNERABILITIES IN CLIENT-SERVER APPLICATIONS

THE BOARD OF TRUSTEES OF ...

1. A method for automatically detecting security vulnerabilities in a client-server application where a client is connected
to a server, the method implemented by a computer having a processor and a software program stored on a non-transitory computer
readable medium, the method comprising:
automatically extracting, with the software program at the client, a description of one or more validation checks on inputs
performed by the client;

analyzing the server, with the software program by using the one or more validation checks on inputs performed by the client,
to determine whether the server is not performing validation checks that the server must be performing; and

determining that security vulnerabilities in the client-server application exist when the server is not performing validation
checks that the server must be performing.

US Pat. No. 9,353,131

METHODS FOR FORMING PROTECTED ORGANOBORONIC ACIDS

The Board of Trustees of ...

1. A method of forming a protected boronic acid, comprising:
reacting in a reaction mixture
a N-substituted morpholine dione, and
an organoboronic acid represented by formula (XII):
R1—B(OH)2  (XII),

wherein
R1 is an organic group, and

the reaction mixture further comprises a polar aprotic solvent; and
thereby forming a protected organoboronic acid represented by formula (III) in the reaction mixture:

 where R10 represents an organic group, and

R11, R12, R13 and R14 independently are selected from the group consisting of a hydrogen group and an organic group.

US Pat. No. 9,328,127

SYSTEM FOR CONTROLLING THE REACTIVITY OF BORONIC ACIDS

The Board of Trustees of ...

1. A method of performing a chemical reaction, comprising:
contacting a protected organoboronic acid with a reagent;
wherein the protected organoboronic acid comprises a boron having an sp3 hybridization, a conformationally rigid protecting group bonded to the boron, and an organic group bonded to the boron through
a boron-carbon bond;

the protected organoboronic acid is represented by formula (X):

R10 represents the organic group;

B represents the boron having sp3 hybridization;

R20 is an organic group; and

R21, R22, R23, and R24 independently are hydrogen;

whereby R10 is chemically transformed; and

the boron is not chemically transformed.

US Pat. No. 9,249,116

ENZYME-ACTIVATING COMPOUNDS AND COMPOSITIONS

The Board of Trustees of ...

13. A method of inducing apoptosis in a cancer cell comprising administering to a cancer cell an effective amount of a compound
of claim 1.
US Pat. No. 9,149,518

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS COMPOSITIONS AND USES THEREOF

The Board of Trustees of ...

1. An isolated Porcine Reproductive and Respiratory Syndrome (PRRS) virus, wherein the virus comprises a nucleic acid sequence
of at least 95% identity to SEQ ID NO:1,
wherein the nucleic acid sequence encodes a Protein E amino acid sequence comprising SEQ ID NO:12 and a GP3 amino acid sequence
comprising SEQ ID NO:16.

US Pat. No. 9,107,881

COMPOSITIONS AND METHODS TO CONTROL ANGIOGENESIS WITH CUPREDOXINS

The Board of Trustees of ...

1. An isolated peptide that is a variant, derivative or structural equivalent of a cupredoxin; and that can inhibit angiogenesis
in mammalian cells.

US Pat. No. 9,097,721

COMPOSITIONS COMPRISING ENGINEERED PHOSPHOTHREONINE AFFINITY REAGENTS, METHODS OF MAKING, AND METHODS OF USE

The Board of Trustees of ...

1. A polypeptide comprising a FHA domain variant derived from the wild-type FHA1 domain of Saccharomyces cerevisiae Rad53 (Rad53) (SEQ ID NO:7), comprising an amino acid sequence having at least one amino acid sequence change that increases
specific binding of the polypeptide to a peptide or polypeptide comprising a phosphothreonine residue, wherein the amino acid
sequence change is in a position, relative to the wild-type FHA1 domain of Rad53, that is S34, N121, W66, Q25, S13, I104,
or R164.

US Pat. No. 9,454,809

PHASE DERIVATIVE MICROSCOPY MODULE HAVING SPECIFIED AMPLITUDE MASK

The Board of Trustees of ...

1. A phase derivative module comprising:
a. a first lens for creating, in a Fourier plane, a field corresponding to a 2D spatial Fourier transform in a spatial frequency
domain of an image field of a sample;

b. an amplitude mask disposed in the Fourier plane, the amplitude mask transmitting a transmitted field characterized by a
central axis, the amplitude mask characterized by a transmission amplitude having a minimum value at the central axis such
that a subsequent Fourier transform of the transmitted field results in a function of a phase component of the image field
of the sample having a term proportional to a power of a derivative of the phase component of the image field;

c. a second lens for transforming the transmitted field back to an image domain showing the derivative of the phase component
at a focal plane of a detector array disposed at an image plane.

US Pat. No. 9,249,087

HDAC INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

THE BOARD OF TRUSTEES OF ...

1. A compound having a structural formula
Cap-L-M
wherein Cap is selected from the group consisting of

wherein ring

 is an aliphatic or aromatic five or six membered ring,
W, X, Y, and Z independently are selected from the group consisting of null, C(R1)2, O, S, and NR1,

ring

 is an aliphatic or aromatic six membered ring,
wherein D, E, F, and G independently are selected from the group consisting of C(R1)2, O, and S,

or ring

 is an aliphatic or aromatic five membered ring, wherein D, E, F, and G are selected from the group consisting of null, C(R1)2, and NR1,

R1, independently, is selected from the group consisting of null, hydrogen, C1-6alkyl, C1-6heteroalkyl, C2-6alkenyl, C1-6perfluoroalkyl, C1-6perfluoroalkoxy, aryl, heteroaryl, C3-10cycloalkyl, C3-10heterocycloalkyl, C1-6alkylenearyl, C1-6alkyleneheteroaryl, C1-6alkyleneheterocycloalkyl, C1-6alkylenecycloalkyl,


 ORa, halo, N(Ra)2, SRa, SORa, SO2Ra, CN, C(?O)Ra, CF3, OCF3, NO2, OC(?O)Ra, SO2N(Ra)2, OSO2CF3, C(?O)ORa, C(?O)N(Ra)2, C1-6alkyleneN(Ra)2, C1-6alkyleneC(?O)Ra, C1-6alkyleneORa, C1-6alkyleneSRa, C1-6alkyleneNRaSO2Ra, C1-6alkyleneSORa, C1-6alkyleneCN, C1-6heteroalkyleneCN, C1-6alkyleneC(?O)ORa, C1-6alkyleneOC(?O)N(Ra)2, C1-6alkyleneNRaC(?O)ORa, C1-6alkyleneNRaC(?O)Ra, C1-6alkylene C(?O)N(Ra)2, C1-6alkyleneOC1-6alkyleneC(?O)ORa, C(?O)NRaSO2Ra, C(?O)C1-6alkylenearyl, C(?O)NRaC1-6alkyleneORa, OC1-6alkyleneC(?O)ORa, OC1-6alkyleneN(Ra)2, OC1-6alkyleneORa, OC1-6alkyleneNRaC(?O)ORa, NRaC1-6alkyleneN(Ra)2, NRaC(?O)Ra, NRaC(?O)N(Ra)2, N(SO2C1-6alkyl)2, and NRa(SO2C1-6alkyl), and

Ra, independently, is selected from the group consisting of hydrogen, C1-6alkyl, C1-6heteroalkyl, C1-6alkyleneNH2, C1-6alkyleneNH(C1-6alkyl), C1-6alkyleneN(C1-6alkyl)2, C1-6alkyleneNH(C1-6alkyl)2, C1-6alkyleneNHC(?O)(C1-6alkyl), C1-6alkyleneC(?O)NH2, C1-6alkyleneOH, C1-6alkyleneCN, C1-6heteroalkyleneCN, C1-6alkyleneOC1-6alkyl, C1-6alkyleneSH, C1-6alkyleneSC1-6alkyl, C1-6alkyleneNH(SO2C1-6alkyl), aryl, heteroaryl, C3-8cycloalkyl, and C3-10heterocycloalkyl,

wherein linker L is attached to any atom D, E, F, or G,

wherein ring

 is an aliphatic or aromatic five or six membered ring,
E, F, W, X, Y, Z, R1, and Ra are as defined above, and


wherein A is C, N, O, S, B, or P, and L is attached to A,
R2, R3 and R4 independently are selected from the group consisting of null, hydrogen, C1-6alkyl, C1-6heteroalkyl, C2-6alkenyl, C1-6perfluoroalkyl, C1-6perfluoroalkoxy, aryl, heteroaryl, C3-10cycloalkyl, C3-8heterocycloalkyl, C1-6alkylenearyl, C1-6alkyleneheteroaryl, C1-6alkyleneheterocycloalkyl, C1-6alkylenecycloalkyl,


 ORa, halo, N(Ra)2, SRa, SORa, SO2Ra, CN, C(?O)Ra, OC(?O)Ra, C(?O)ORa, C1-6alkyleneN(Ra)2, C1-6alkyleneORa, C1-6alkyleneSRa, C1-6alkyleneC(?O)ORa, C(?O)N(Ra)2, C(?O)NRaC1-6alkyleneORa, OC1-6alkyleneC(?O)ORa, OC1-6alkyleneN(Ra)2, OC1-6alkyleneORa, OC1-6alkyleneNRaC(?O)ORa, NRaC1-6alkyleneN(Ra)2, NRaC(?O)Ra, NRaC(?O)N(Ra)2, N(SO2C1-6alkyl)2, NRa(SO2C1-6alkyl), nitro, and SO2N(Ra)2, and

Ra is defined above;

L is selected from the group consisting of null, C1-8alkylene, Ra substituted C1-8alkylene, NRa, C(?O), aryl, C(?O)aryl, C(?O)C1-6alkylene, C1-8alkyleneNRa, C1-6alkylenearyleneC1-6alkylene, C2-6alkenylene, C4-8alkdienylene, C1-6alkylenearylene, C1-6alkyleneheteroarylene, Ra substituted C1-6alkyleneheteroarylene, and C2-6alkenylenearyleneC1-6alkylene, and Ra is defined above;

M is selected from the group consisting of —C(?O)N(Rb)OH,

—O(CH2)1-6C(?O)N(Rb)ORb,

—N(Rb)(CH2)1-6C(?O)N(Rb)ORb,

—N(Rb)(CH2)1-6C(?O)N(Rb)ORb,

arylC(?O)NHOH,
—N(OH)C(?O)Rb,

heteroarylC(?O)NHOH,
—C3-6cycloalkylN—C(?O)CH2SH,

—B(ORb)2,

—SO2NHRb,

—NHSO2NHRb,

—NHSO2C1-6alkyl,

—SO2C1-6alkyl,

—SRc,


—C(?O)Re,

—P(?O)(ORf)2,

—NH—P(?O)(ORf)2,


—C(?O)(C(Rb)2)1-6SH,

—C(?O)C(?O)NHRb,

—C(?O)NHN(Rb)2,

—C(?O)NH(CH2)1-3N(Rb)2,


—S—(C?O)C1-6alkyl,

C3-10heterocycloalkyl optionally substituted with oxo (?O), thioxo (?S), or both,

aryl optionally substituted with one or more of C1-6alkyl, —C(?O)Rd, —NH2, and —SH,

heteroaryl optionally substituted with —NH2, —SH, or both,

—N(H)C(?O)SH,
—NHC(?O)NHRd,

—NHC(?O)CH2Rd,

—NHC(?O)(CH2)1-6SH,

—NHC(?O)CH2Hal,

—NHC(?S)NHRd,

—NHC(?S)CH2Rd,

—C(?S)NHRd,

—C(?S)CH2Rd,

—NHC(?S)CH2Rd,

—NHC(?S)CH2Hal, and

—(C?O)C1-6alkyl;

Rb, independently, is selected from the group consisting of hydrogen, (C?O)CH3, C1-6alkyl, CF3, CH2F, and aryl, or two Rb groups are taken together with the carbon to which they attached to form a C3-8cycloalkyl group;

Rc is selected from hydrogen or (C?O)CH3;

Rd is NH2 or OH;

Re is selected from the group consisting of OH, N(Rb)2, NH(OCH3), N(CH3)OH, C1-6alkyl, CF3, aryl, heteroaryl, C3-8cycloalkyl, NHSO2CH3, NHSO2CF3, and C1-6haloalkyl;

Rf independently is hydrogen, methyl, or ethyl; and

Hal is halo,
or a pharmaceutically acceptable salt, hydrate, or prodrug thereof.
US Pat. No. 9,241,471

PRAIRIE CORDGRASS (SPARTINA PECTINATA) CULTIVAR ‘SAVOY’ FOR A BIOENERGY FEEDSTOCK PRODUCTION

The Board of Trustees of ...

1. Seed of prairie cordgrass cultivar designated ‘Savoy’, representative seed of said cultivar having been deposited under
ATCC Accession Number PTA-120691.

US Pat. No. 9,171,733

METHOD OF SELECTIVELY ETCHING A THREE-DIMENSIONAL STRUCTURE

The Board of Trustees of ...

1. A method of selectively etching a three-dimensional structure, the method comprising:
initiating generation of a plasma in contact with a three-dimensional structure;
illuminating a designated portion of the three-dimensional structure with a pulsed laser beam while the plasma is being generated,
the laser beam having an energy density of no more than about 100 mJ/cm2 per pulse;

plasma etching nonilluminated portions of the three-dimensional structure at a first etch rate; and
plasma etching the designated portion of the three-dimensional structure at a second etch rate, the second etch rate being
different from the first etch rate,

wherein the three-dimensional structure is provided on a substrate prior to initiating the generation of the plasma.
US Pat. No. 9,134,298

COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS

The Board of Trustees of ...

1. A pharmaceutical composition, comprising:
at least one peptide that is a truncation of a cupredoxin and that can inhibit the development of premalignant lesions in
mammalian tissue; and

a pharmaceutically acceptable carrier.

US Pat. No. 9,330,910

METHOD OF FORMING AN ARRAY OF NANOSTRUCTURES

The Board of Trustees of ...

1. A method of forming an array of nanostructures, the method comprising:
forming a plurality of seed points on a surface of a substrate;
growing masks from the seed points to create masked regions of the substrate underlying the masks, a remainder of the substrate
comprising an unmasked region, each mask and masked region increasing in size with growth time while the unmasked region of
the substrate decreases in size;

during the growing, etching the unmasked region to remove material from the substrate in a depth direction, and
during the etching, forming unetched structures from the masked regions of the substrate, each unetched structure having a
lateral size that increases with depth.

US Pat. No. 9,248,198

PEPTIDE COMPOSITIONS AND METHODS FOR TREATING LUNG INJURY, ASTHMA, ANAPHYLAXIS, ANGIOEDEMA, SYSTEMIC VASCULAR PERMEABILITY SYNDROMES, AND NASAL CONGESTION

THE BOARD OF TRUSTEES OF ...

1. A method of treating anaphylaxis-mediated vascular leakage, inflammation-mediated vascular leakage and IgE-mediated anaphylaxis,
comprising administering to a patient in need thereof a composition comprising an isolated peptide comprising the amino acid
sequence KFARLWTEIPTAIT (SEQ ID NO: 1) or FTEIPTI (SEQ ID NO: 3).

US Pat. No. 9,116,692

SYSTEM AND METHOD FOR IMPROVING POWER CONVERSION FOR ADVANCED ELECTRONIC CIRCUITS

THE BOARD OF TRUSTEES OF ...

1. A system comprising:
a circuit having a plurality of electronic function blocks electrically interconnected in series;
a power source unit coupled to the circuit, for supplying power to the plurality of electronic function blocks electrically
interconnected in series; and

a control unit coupled to each of the plurality of the electronic function blocks and to the power source unit, wherein the
control unit is configured to monitor activity levels of each of the electronic function blocks, and wherein the control unit
adjusts the activity level of each of the plurality of electronic function blocks, determines a voltage level suitable for
the corresponding adjusted activity level, determines a current level suitable for the plurality of function blocks electrically
interconnected in series, and adjusts the power supplied to each of the plurality of electronic function blocks in order to
achieve the corresponding determined voltage and current levels at each of the plurality of electronic function blocks.

US Pat. No. 9,169,465

NON-SIMIAN CELLS FOR GROWTH OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) VIRUS

The Board of Trustees of ...

1. A method of isolating a cell from a porcine fetal lung, comprising the steps of providing a porcine fetal subject; obtaining
a cell-containing sample from said subject; separating a cell from said sample, and culturing the sell for at least 5 passages,
wherein the cell is capable of replicating porcine reproductive and respiratory syndrome (PRRS) virus; thereby isolating said
cell.

US Pat. No. 9,324,422

ADAPTIVE RESISTIVE DEVICE AND METHODS THEREOF

THE BOARD OF TRUSTEES OF ...

1. A device, comprising:
a nanoelectrode comprising a gap; and
a resistive change material located in the gap, wherein an application of a voltage potential across first and second terminals
of the nanoelectrode causes the resistive change material to modify at least one non-volatile memory state of the resistive
change material.

US Pat. No. 9,302,218

CHEMICALLY-ENHANCED SORBENT ACTIVATION PROCESS AND METHODS FOR USING SAME

The Board of Trustees of ...

1. A method for adding an activated sorbent to a gas stream comprising at least one gaseous pollutant, comprising:
separating a first gas stream comprising an activated sorbent into a stream of said activated sorbent and a separated gas
stream, wherein said first gas stream comprises a gas stream used to activate a sorbent precursor to produce said activated
sorbent;

adding said activated sorbent from said stream of said activated sorbent to a second gas stream comprising at least one gaseous
pollutant, wherein said activated sorbent is capable of adsorbing said at least one gaseous pollutant;

adding an oxidant to said separated gas stream;
oxidizing carbon monoxide in said separated gas stream; and
adding, after said oxidizing, said separated gas stream to said second stream.

US Pat. No. 9,224,809

FIELD EFFECT TRANSISTOR STRUCTURE COMPRISING A STACK OF VERTICALLY SEPARATED CHANNEL NANOWIRES

The Board of Trustees of ...

1. A field effect transistor structure comprising:
a source and a drain on a substrate; and
a stack of n vertically separated channel nanowires isolated from the substrate and connecting the source and the drain, where
n is an integer and 2?n?20, and where a vertical direction is substantially perpendicular to the substrate, the n vertically
separated channel nanowires collectively comprising at least two different thicknesses and/or at least two different dopant
concentrations and/or at least two different semiconductor materials.

US Pat. No. 9,157,550

MICROFLUIDIC SYSTEMS AND METHODS

The Board of Trustees of ...

25. A microfluidic system for assaying a plurality of cells, the microfluidic system comprising:
a PDMS substrate;
a base coupled to said substrate; and
a plurality of microfluidic channels arranged in the substrate and formed by microfabrication, each of said plurality of microfluidic
channels comprising:

a source channel at an end of said microfluidic channel and a sink channel at an opposing end, said source channel and said
sink channel having an inlet and an outlet;

a cell chamber disposed within said microfluidic channel between said source channel and said sink channel;
a cell inlet in fluid communication with said cell chamber; and
wherein fluid flow is restricted and diffusion is permitted between said cell chamber and said sink channel; and
wherein fluid flow is restricted and diffusion is permitted between said cell chamber and said source channel;
wherein the cell chamber narrows in width along a direction from one of said source channel and said sink channel to the other
of said source channel and said sink channel to a narrow portion of the microfluidic channel that is disposed between said
cell chamber and the other of said source channel and said sink channel, wherein the narrow portion provides fluidic resistance
and permits diffusion;

wherein the inlet and the outlet of said source channel, the inlet and outlet of said sink channel, and said cell inlet for
each of the plurality of microfluidic channels are aligned in two-dimensional arrays on said substrate;

wherein said cell chamber is configured to provide a radial concentration gradient within the cell chamber.

US Pat. No. 9,127,972

SELF-CALIBRATING MASS FLOW SENSOR SYSTEM

The Board of Trustees of ...

1. A method of calibrating a mass flow sensor in a machine, the machine including a housing, a mass flow system to move solid
particles and propel particles through a path toward a portion of the housing, the mass flow sensor disposed to determine
a mass of particles propelled through the path toward a portion of the housing and generate a corresponding sensor output,
and an actuator to adjust at least one measurable parameter of the mass flow sensor to affect the sensor output, and a processor
to receive the sensor output and control the actuator, the method comprising:
by the processor, applying a model relating a mass flow input to the sensor output, the model including at least one internal
parameter and the at least one measurable parameter;

by the actuator, varying the at least one measurable parameter over a plurality of samples;
by the processor, for each of the plurality of samples, receiving the generated sensor output;
by the processor, measuring a mass flow input for mass flow that occurs while conducting said varying; and
by the processor, updating the model by updating the at least one internal parameter in said model based on the mass flow
input for each of the plurality of samples, the received sensor output for each of the plurality of samples, and the varied
measurable parameter for each of the plurality of samples.

US Pat. No. 9,394,050

CONTROLLED TRANSITORY OR SUSTAINED GLIDING FLIGHT WITH DIHEDRAL ANGLE AND TRAILING FLAPS

The Board of Trustees of ...

1. A micro aerial vehicle capable of controlled transitory or sustained gliding flight, comprising:
a fuselage; and
a pair of articulated wings forward of a center of gravity of the vehicle, the wings being articulated and having trailing
edge flaps, and having actuators for controlling the dihedral angles of the wings and the flaps for effective yaw control
across the flight envelope, wherein the dihedral angles can be varied symmetrically on both wings to control the aircraft
speed independently of the angle of attack and flight-path angle, while an asymmetric dihedral setting can be used to control
yaw and the actuators control the dihedral settings of each wing independently;

wherein the aircraft lacks a vertical tail or other vertical stabilizer.
US Pat. No. 9,273,115

METHOD FOR CONTROLLING THE BIOLOGICAL ACTIVITY OF A PROTEIN IN A VERTEBRATE CELL

CENTRE NATIONAL DE LA REC...

1. A method for controlling the biological activity of a protein of interest in a vertebrate cell, said protein of interest
in a vertebrate cell being expressed in said cell in the form of a fusion protein wherein said fusion protein comprises:
(i) a polypeptide comprising a mutated form of the ligand binding domain of the human oestrogen receptor alpha of sequence
SEQ ID NO: 3, wherein said mutated form has the mutations L346I, A350M, M388Q, G442Y, Y459N, L466S, G521S and Y526D relative
to SEQ ID NO: 3, wherein said polypeptide selectively binds a synthetic ligand devoid of oestrogenic and anti-oestrogenic
activities, and

(ii) said protein of interest, wherein the biological activity of said protein of interest is induced by said synthetic ligand,
said method comprising:
a) providing a vertebrate cell expressing said fusion protein;
b) contacting said vertebrate cell with said synthetic ligand to induce the biological activity of said fusion protein in
said cell; and

c) recovering the biological activity of said fusion protein in said vertebrate cell,
wherein said protein of interest is selected from the group consisting of cytokines, hormones. transcription factors, signaling
modules, enzymes oncoproteins and tumor-suppressor proteins.

US Pat. No. 9,248,428

REGENERABLE OXIDE-BASED ADSORBENT

The Board of Trustees of ...

1. A zinc titanate reactive adsorbent comprising multiphase, polycrystalline nanofibers comprising ZnTiO3, ZnO, TiO2, and Zn2TiO4, and having a diameter ranging from 350 to 800 nm,
the nanofibers further comprising primary fibers having a second ratio Zn/Ti and secondary nanorods having a first ratio Zn/Ti
branching off from the primary fibers, the first ratio Zn/Ti being greater than the second ratio Zn/Ti.

US Pat. No. 9,212,258

AMPHIPHILIC DENDRON-COILS, MICELLES THEREOF AND USES

THE BOARD OF TRUSTEES OF ...

1. A micelle comprising amphiphilic dendron-coils, wherein each amphiphilic dendron-coil comprises a non-peptidyl, hydrophobic
core-forming block, a polyester dendron and a poly(ethylene) glycol (PEG) moiety, and wherein the non-peptidyl, hydrophobic
core-forming block comprises a linear hydrophobic polymer.
US Pat. No. 9,265,785

COMPOSITIONS COMPRISING DECITABINE AND TETRAHYDROURIDINE AND USES THEREOF

The Board of Trustees of ...

1. A composition for oral administration comprising decitabine, tetrahydrouridine, and a pharmaceutically acceptable excipient,
wherein said composition comprises about 1 to about 9.9 mg/m2 decitabine and about 300 to about 500 mg/m2 tetrahydrouridine.
US Pat. No. 9,376,713

LABEL FREE DETECTION OF NUCLEIC ACID AMPLIFICATION

The Board of Trustees of ...

1. A method of detecting a nucleic acid amplification product in solution, said method comprising:
providing a microfluidic amplification chamber comprising an electrode array on at least one surface of said microfluidic
amplification chamber;

introducing a solution that may contain a template to be amplified by nucleic acid amplification in said microfluidic amplification
chamber;

performing a nucleic acid amplification on said solution, wherein said nucleic acid amplification is performed in a confined
region or said nucleic acid amplification product is contained in a confined region, to generate an amplified nucleic acid
amplification product in solution, wherein said confined region has a volume selected from a range that is greater than or
equal to 0.5 pL and less than or equal to 1 nL;

applying an electric potential to said electrode array to produce an electric field in said confined region; and
measuring an electrical parameter of said solution in said confined region, wherein said electrical parameter is solution
impedance, thereby detecting said nucleic acid amplification product in solution;

wherein said step of introducing the solution comprises:
providing a droplet of the solution surrounded by a suspending fluid comprising an ionic liquid, and the droplet corresponds
to the confined region; and

electrically contacting the droplet with the electrode array;
wherein said detection of nucleic acid amplification is label-free.
US Pat. No. 9,309,292

TRANSPORT AGENTS FOR CROSSING THE BLOOD-BRAIN BARRIER AND INTO BRAIN CANCER CELLS, AND METHODS OF USE THEREOF

The Board of Trustees of ...

1. A complex comprising at least one cargo compound and a transit peptide, wherein the transit peptide comprises a Neisseria transit peptide, an AAEAP (SEQ ID NO: 25), or an H.8 region from Neisseria gonorrhoeae F62 Laz protein (SEQ ID NO: 24) and wherein the at least one cargo compound and the transit protein are physically associated
with one another.

US Pat. No. 9,351,752

INSERTION TOOL FOR A SPINAL CORD STIMULATION ELECTRODE

THE BOARD OF TRUSTEES OF ...

1. An insertion tool for a spinal cord stimulation electrode, the insertion tool comprising:
a first leg;
a second leg coupled to the first leg, the first and second legs being separable for placement around the electrode and resiliently
returning to a clamped position, each of the first and second legs generally defining a respective longitudinal axis, each
of the first and second legs defining a blade portion offset from the respective longitudinal axis, wherein each of the offset
blade portions include an electrode-receiving channel formed therein extending from a proximal-most end of the blade portion
to a distal-most end of the blade portion, wherein the electrode receiving channels of each of the first and the second legs
are configured to clamp the electrode, wherein the offset blade portions are so dimensioned as to facilitate inserting the
electrode into an epidural space and advancing the electrode along the epidural space;

wherein each of the first and second legs includes a respective intermediate angled portion that elevates a first portion
of each of the first leg and the second leg above a second portion of each of the first and the second legs, respectively,
and

wherein the respective blade portions are elevated above both the respective first portions and the second portions of the
first and the second legs.

US Pat. No. 9,278,522

HIGH RESOLUTION SENSING AND CONTROL OF ELECTROHYDRODYNAMIC JET PRINTING

The Board of Trustees of ...

1. An electrohydrodynamic jet printing device comprising:
one or more printing nozzles configured to contain a printable fluid;
a substrate configured to receive ejected printable fluid from the one or more printing nozzles;
a current or voltage sensor electrically connected to the substrate for measuring output current or voltage during printing
for real-time feedback and feedforward control;

a voltage or current generator operably connected to the one or more printing nozzles configured to establish an electric
potential difference between the one or more printing nozzles and the substrate and controllably eject printable fluid from
the nozzle onto the substrate;

a controller electrically connected to said sensor for controlling the voltage or current generator to maintain a desired
printing condition based on the measured output current or voltage during printing by the current or voltage sensor for real-time
feedback control and a process map for real-time feedforward control;
wherein the process map is generated by detecting current spikes during printing to determine jetting frequency for one or
more process parameters; andwherein said device provides a print resolution that is selected from a range between 10 nm to 10 ?m for a printing frequency
selected from a range that is greater than 0 Hz and less than or equal to 100 kHz and a placement accuracy that is better
than 500 nm.

US Pat. No. 9,242,873

CO-DOPED TITANIUM OXIDE FOAM AND WATER DISINFECTION DEVICE

The Board of Trustees of ...

1. A quaternary oxide foam, comprising an open-cell foam comprising titanium oxide containing:
(a) a dopant metal comprising palladium,
(b) a dopant nonmetal,
(c) titanium, and
(d) oxygen,
wherein the dopant metal is present at a concentration of at most 2 wt. %, and wherein the open-cell foam comprises a pore
size distribution having at least two peaks.

US Pat. No. 9,318,082

LEADPIPE OR MOUTHPIPE SYSTEM FOR TROMBONE OR OTHER BRASS INSTRUMENT

The Board of Trustees of ...

1. A leadpipe comprising:
a sidewall defining an enclosed channel, the sidewall having an upstream end and a downstream end;
wherein the sidewall is comprised of a plurality of sections including a first tapered section upstream of at least one subsequent
section;

wherein each of the sections extends longitudinally between the upstream end of the sidewall and the downstream end of the
sidewall;

wherein the first tapered section is disposed upstream of the at least one subsequent sections;
wherein the first tapered section and at least one subsequent section of the sidewall each define a generally frustoconical
cavity having an upstream end with an upstream inner diameter Df and a downstream end with a downstream inner diameter Ds;

wherein the downstream inner diameter of each of the sections is larger than the upstream inner diameter; and
wherein each of the sections has a length L and a taper T, wherein the taper is defined as T=(Ds?Df)/L, wherein the taper
of the first tapered section is larger than the taper of each of the subsequent sections, and wherein the taper of each of
the subsequent sections is less than the taper of the section immediately upstream.

US Pat. No. 9,448,173

DYE-CONJUGATED DENDRIMERS

The Board of Trustees of ...

1. A dendrimer of Formula I:

wherein
the circle of Formula I is a G2-G10 dendrimer;
each R is independently a dye moiety covalently bonded to a branch of the dendrimer;
each linker-X is independently the same or different, wherein linker is S, NH, or O, or a chain of 2-40 atoms that connects
a branch of the dendrimer to a group X;

each X is independently R, a reactive group, an affinity label, or a targeting moiety;
n is a value representing about 1% to about 50% of terminal dendrimer groups;
m is a value representing 0% to about 50% of terminal dendrimer groups;
s is a value representing 1% to about 60% of terminal dendrimer groups; and
t is a value representing 0% to about 60% of terminal dendrimer groups;
wherein at least two R groups are different from each other; and wherein the dye moieties of at least two different R groups
comprise at least two different Cyanine dyes;

the photobleaching lifetime of the dendrimer is more than 2 times longer than the photobleaching lifetime of a single dye
separate from the dendrimer;

the fluorescence emission intensity of the dendrimer is at least two times brighter than a corresponding single dye molecule;
and

the diameter of the dendrimer is less than about 20 nm;
or a salt thereof.

US Pat. No. 9,412,442

METHODS FOR FORMING A NANOWIRE AND APPARATUS THEREOF

The Board of Trustees of ...

1. A device, comprising:
a first circuit component;
a second circuit component; and
a nanowire coupled to a first teiminal of the first circuit component, and a second terminal of the second circuit component,
wherein the nanowire forms a conductive channel between the first circuit component and the second circuit component,
wherein the nanowire comprises a phase change material deposited in a trench aligned with a nanoelectrode, wherein the phase
change material covers the nanoelectrode, and wherein an outer surface of the phase change material conforms to an outer surface
of the nanoelectrode, and

wherein the nanoelectrode has a nanogap formed therethrough without being formed in the phase change material.

US Pat. No. 9,326,523

CLASS I AND II LANTIBIOTICS FROM GEOBACILLUS THERMODENITRIFICANS

The Board of Trustees of ...

1. An isolated geobacillin comprising the structure of:

US Pat. No. 9,217,094

SUPERHYDROPHOBIC COMPOSITIONS

The Board of Trustees of ...

1. A superhydrophobic dispersion composition comprising:
a. a water dispersible hydrophobic component, wherein the hydrophobic component comprises a perfluorinated polymer modified
with a comonomer;

b. a nanoclay comprising nano-structured particles; and
c. water, wherein a surface treated with the superhydrophobic dispersion has a water contact angle greater than 150°, wherein
the superhydrophobic composition is free of an organic solvent, wherein the ratio of the weight of the nanoclay to the weight
of the nanoclay and the hydrophobic component is above 0.2 and less than 0.5.

US Pat. No. 9,218,906

NANO-CAPACITOR ARRAYS FOR ENERGY STORAGE USING NATIVE ALUMINUM OXIDE LAYERS AND OTHER ULTRA-THIN DIELECTRICS

The Board of Trustees of ...

1. A method for storing energy, the method comprising:
a. providing an array of nanocapacitor cells, each capacitor cell including (1) a cathodic electrode; and
(2) an anode spaced apart from the cathodic electrode by an intervening dielectric characterized by a thickness normal to
the cathodic electrode and by an electron mean free path,

wherein a thickness of the intervening dielectric is in the range between 0.1 nanometers and 1000 nanometers and is smaller
than the electron mean free path within the dielectric, and wherein the cathodic electrode is at least 100 times larger than
the thickness of the intervening dielectric in every direction transverse to the thickness dimension of the intervening dielectric;
and

b. storing an excess of electrons on the cathodic electrode.

US Pat. No. 9,330,829

ROLLED-UP TRANSFORMER STRUCTURE FOR A RADIOFREQUENCY INTEGRATED CIRCUIT (RFIC)

The Board of Trustees of ...

1. A rolled-up transformer structure for a radiofrequency integrated circuit (RFIC), the rolled-up transformer structure comprising:
a multilayer sheet in a rolled configuration comprising multiple turns about a longitudinal axis, the multilayer sheet comprising
a conductive pattern layer on a strain-relieved layer, the conductive pattern layer comprising a first conductive film separated
from a second conductive film in a rolling direction,

wherein the first conductive film comprises an even number of primary conductive strips, each of the primary conductive strips
having a length extending in the rolling direction,

wherein the second conductive film comprises an even number of secondary conductive strips, each of the secondary conductive
strips having a length extending in the rolling direction,

wherein, in the rolled configuration, the primary conductive strips wrap around the longitudinal axis and the secondary conductive
strips wrap around the primary conductive strips, the primary conductive strips being a primary winding and the secondary
conductive strips being a secondary winding of the rolled-up transformer structure.

US Pat. No. 9,295,651

NANOCONJUGATES AND NANOCONJUGATE FORMULATIONS

The Board of Trustees of ...

1. A drug-polymer nanoconjugate composition comprising drug-polymer nanoconjugate particles having a block copolymer coating,
and an albumin coating;
wherein the drug-polymer nanoconjugate particles comprise one or more drugs and one or more polymers, and the one or more
drugs of the drug-polymer nanoconjugate particles are individually covalently bonded to initiation points of individual polymers
of the drug-polymer nanoconjugate particles through ether or thioether moieties;

the one or more polymers of the drug-polymer nanoconjugate particles comprise polyester, polycarbonate, polyphosphate, polysiloxane,
polyphosphazane, polypeptide, or amino acid oligomers segments, or a combination thereof;

the block copolymer coating comprises PEG and lactide blocks; and
the block copolymer coating is coated with an amount of albumin effective to at least substantially prevent aggregation of
the drug-polymer nanoconjugate particles when in contact with other drug-polymer nanoconjugates particles, wherein the ratio
of the mass of albumin coating to the total mass of the drug-polymer nanoconjugate particles is about 2:1 to about 20:1; and

wherein the composition has a diameter of about 2 nm to about 300 nm and a mass of less than 2 wt. % of total drugs that are
not covalently bonded to the polymer.

US Pat. No. 9,263,600

SILICON NANOPARTICLE PHOTOVOLTAIC DEVICES

The Board of Trustees of ...

1. A photovoltaic device for converting light into electrical power, comprising:
means for accepting and converting light of a predetermined wavelength range into electrical power; and
a film consisting substantially of luminescent silicon nanoparticles optically coupled to said means for accepting and converting
light, said film having a predetermined thickness, said film responding to incident radiation and producing light response
in the predetermined wavelength range that is optically coupled into said means for accepting and converting light.

US Pat. No. 9,562,059

ANTICANCER MAYTANSINOIDS WITH TWO FUSED MACROCYCLIC RINGS

Hong Kong Baptist Univers...

1. A method of treating cancer, comprising: administering daily a composition comprising an effective dose of at least one
compound selected from the group consisting of

wherein R1, R2, and R3 are independently selected from the group consisting of hydrogen and an alkyl group having 1 to 6 carbon atoms,
and
wherein R is CH2CH2CH3.

US Pat. No. 9,397,370

SINGLE AND MULTIPLE CELL BATTERY WITH BUILT-IN CONTROLLER

The Board of Trustees of ...

1. An electronic device comprising:
a battery comprising a container including a positive terminal and a negative terminal;
an electrochemical cell disposed within said container, said cell having a positive electrode, a negative electrode and a
cell voltage measured across said positive electrode and said negative electrode of said cell; and

a controller to monitor said cell for each of the following conditions within said cell: over temperature, short-circuit,
overcharge, and over-discharge and to provide a safety disconnect when one of said conditions exist.

US Pat. No. 9,605,054

COMPOSITION AND METHOD FOR TREATING A TAUOPATHY

The Board of Trustees of ...

1. A vaccine composition comprising a tau peptide consisting of SEQ ID NO:1 that stimulates production of an antibody that
binds Paired Helical Filament tau but does not bind non-denatured, soluble monomeric tau, wherein said tau peptide is in admixture
with an immunostimulatory adjuvant and said tau peptide is not post-translationally modified.

US Pat. No. 9,691,873

TRANSIENT DEVICES DESIGNED TO UNDERGO PROGRAMMABLE TRANSFORMATIONS

The Board of Trustees of ...

1. An actively triggered transient electronic device comprising:
a substrate;
one or more inorganic components supported by said substrate; wherein said one or more inorganic components independently
comprise a selectively transformable material, wherein said one or more inorganic components have a preselected transience
profile in response to an external or internal stimulus;

a silk overcoat provided on at least a portion of said one or more inorganic components; and
an actuator responsive to a user initiated external trigger signal and operably connected to said one or more inorganic components,
wherein upon said device receiving said external trigger signal said actuator at least partially removes said silk overcoat
so as to expose at least a portion of said one or more inorganic components to said external or internal stimulus, thereby
providing a programmable transformation of the actively triggered transient electronic device in response to said external
trigger signal, wherein said programmable transformation provides a change in function of the actively triggered transient
electronic device from a first condition to a second condition.

US Pat. No. 9,263,558

HYBRID PLASMA-SEMICONDUCTOR TRANSISTORS, LOGIC DEVICES AND ARRAYS

The Board of Trustees of ...

1. A flexible hybrid plasma semiconductor device, comprising:
a thin and flexible semiconductor base layer;
an emitter region diffused into said thin and flexible base layer forming a pn-junction;
an insulator layer upon one side of said thin and flexible semiconductor base layer and said emitter region;
base and emitter electrodes isolated from each other by said insulator layer and electrically contacting said thin and flexible
semiconductor base layer and said emitter region through said insulator layer;

a thin and flexible collector layer upon an opposite side of said thin and flexible semiconductor base layer;
a microcavity formed in said thin and flexible collector layer aligned with said emitter region;
collector electrodes arranged to sustain a microplasma within said microcavity with application of voltage to said collector
electrodes, wherein a depth of said emitter region and a thickness of said thin and flexible semiconductor base layer are
set to define a predetermined thin portion of said base layer as a base region between said emitter region and said microcavity
and microplasma generated in said microcavity serves as a collector.

US Pat. No. 9,359,666

RAPID CRYSTALLIZATION OF HEAVILY DOPED METAL OXIDES AND PRODUCTS PRODUCED THEREBY

The Board of Trustees of ...

10. A doped metal oxide structure comprising:
a substrate;
a first doped metal oxide on the substrate, the first doped metal oxide comprising a metal oxide and a dopant nonmetal; and
a crystallized doped metal oxide directly on the first doped metal oxide, the crystallized doped metal oxide comprising the
same metal oxide and the same dopant nonmetal,

wherein the crystallized doped metal oxide has a different crystal structure than the first doped metal oxide, and
wherein an atomic ratio of metal to oxygen to the dopant nonmetal in the first doped metal oxide is 1:0.5-1.99:0.01-1.5.

US Pat. No. 9,324,733

CONTROLLED BUCKLING STRUCTURES IN SEMICONDUCTOR INTERCONNECTS AND NANOMEMBRANES FOR STRETCHABLE ELECTRONICS

The Board of Trustees of ...

1. A multilayer device comprising:
a flexible substrate;
an intermediate layer that is supported on a surface of the flexible substrate;
a first device layer disposed over the flexible substrate and at least partially embedded in the intermediate layer, the first
device layer comprising:

a first device component that forms part of a two-dimensional array;
at least two stretchable interconnects, each of the at least two stretchable interconnects having a first end, a second end,
and a central portion that is between the first and the second end, wherein:

the at least two stretchable interconnects extend along at least two different directions from the first device component
in a plane of the supporting surface to form the two dimensional array;

the first end of each of the at least two stretchable interconnects is in electrical communication with the first device component;
the central portion of each of the at least two stretchable interconnects comprises a bent configuration region;
an interlayer disposed over the first device layer, the interlayer comprising a polymeric material;
a second device layer disposed over the interlayer, the second device layer comprising a second device component; and
an electrical interconnect having a first end and a second end, the electrical interconnect extending through a portion of
the interlayer,

wherein the first end of the interconnect is in electrical communication with the first device component, and
wherein the second end of the interconnect is in electrical communication with the second device component.

US Pat. No. 9,601,671

OPTICAL SYSTEMS FABRICATED BY PRINTING-BASED ASSEMBLY

The Board of Trustees of ...

1. A display system comprising:
a device substrate;
a plurality of printed light-emitting diodes on a surface of the device substrate, wherein each light-emitting diode of the
plurality of light-emitting diodes has at least one physical dimension less than or equal to 200 microns; and

a planarizing layer on the surface of the device substrate, wherein the planarizing layer is in contact with only a portion
of each side of the light-emitting diodes that are non-parallel to the device substrate, and has a substantially flat surface
opposite the device substrate.

US Pat. No. 9,096,663

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO EPHRIN SIGNALING WITH CUPREDOXINS AND MUTANTS THEREOF

The Board of Trustees of ...

1. An isolated peptide comprising a sequence selected from the group consisting of SEQ ID NOS: 35-36 and 38, and wherein the
isolated peptide is a cupredoxin or a truncation of a cupredoxin and is capable of binding an ephrin receptor.

US Pat. No. 9,577,162

OPTICAL SYSTEMS FABRICATED BY PRINTING-BASED ASSEMBLY

The Board of Trustees of ...

1. A display system comprising:
a device substrate;
a plurality of printed light-emitting diodes on a surface of the device substrate, wherein each light-emitting diode of the
plurality of light-emitting diodes has at least one physical dimension less than or equal to 200 microns; and

a planarizing layer on the surface of the device substrate, wherein the planarizing layer is in contact with only a portion
of each side of the light-emitting diodes that are non-parallel to the device substrate, and has a substantially flat surface
opposite the device substrate.

US Pat. No. 9,504,274

METHODS OF FLAVOR ENCAPSULATION AND MATRIX-ASSISTED CONCENTRATION OF AQUEOUS FOODS AND PRODUCTS PRODUCED THEREFROM

Frito-Lay North America, ...

1. An improved method for encapsulating flavors in which a prolamin is dissolved to form a prolamin solution, a flavor is
mixed with the prolamin solution to form a mixed solution, and the mixed solution is dried to form a powder comprising prolamin-encapsulated
flavor, wherein the improvements comprise:
prior to said mixing step, dispersing an aqueous food in an alcohol solution by sonicating the solution, wherein said aqueous
food comprises bioactive components, wherein said bioactive components comprise said flavor; and

wherein said mixing step comprises combining said aqueous food with said prolamin solution, thereby initiating concentration
of said bioactive components of said aqueous food, said prolamin-encapsulated flavor further comprising said bioactive components.

US Pat. No. 9,105,555

STRETCHABLE FORM OF SINGLE CRYSTAL SILICON FOR HIGH PERFORMANCE ELECTRONICS ON RUBBER SUBSTRATES

The Board of Trustees of ...

1. A stretchable electronic circuit comprising:
a flexible substrate;
an electronic circuit comprising at least one stretchable semiconductor structure, the electronic circuit being supported
by the surface of the flexible substrate; and

an encapsulating layer or coating, the encapsulating layer or coating comprising an additive, the additive comprising at least
one of a fiber, paper, foil, a structural enhancer or a filler;

wherein the encapsulating layer or coating at least partially encapsulates the at least one stretchable semiconductor structure;
wherein the at least partially embedded portion of the electronic circuit comprises the at least one stretchable semiconductor
structure;

wherein the at least one stretchable semiconductor structure has a curved internal surface that provides stretchability to
isolate the electronic circuit from an applied strain; and

wherein the encapsulating layer or coating modifies the range of stretchability of the at least one stretchable semiconductor
structure.

US Pat. No. 9,464,985

PLASMON RESONANCE IMAGING APPARATUS HAVING NANO-LYCURGUS-CUP ARRAYS AND METHODS OF USE

The Board of Trustees of ...

1. An apparatus, comprising:
an array layer having a top surface and a bottom surface, wherein a plurality of nanoholes are defined in the top surface
of the array layer, wherein the plurality of nanoholes each have at least one sidewall surface and a bottom surface;

a thin metal film disposed on the top surface of the array layer and on the bottom surface of each of the plurality of nanoholes;
and

a plurality of nanoparticles disposed on the at least one sidewall surface of the plurality of nanoholes.
US Pat. No. 9,249,446

APPARATUS AND METHOD FOR DETECTING AND IDENTIFYING MICROORGANISMS

The Board of Trustees of ...

1. An apparatus for detecting, quantifying or identifying a microorganism comprising
(a) a container with at least one chamber;
(b) a medium within the chamber of the container, wherein said medium is supplemented with nutrients for supporting growth
of a microorganism; and

(c) at least one colorimetric sensing element placed in, or proximate to, the medium, wherein said sensing element includes
a substrate comprising a plurality of chemoresponsive dyes in a predetermined pattern combination, wherein monitoring spectroscopic,
transmission or reflectance responses of the plurality of chemoresponsive dyes is used to detect, quantify, or identify a
microorganism.

US Pat. No. 9,113,798

METHOD AND APPARATUS FOR VETERINARY CT SCANS

The Board of Trustees of ...

1. An enclosure comprising:
an open base structure; and
a lid which is configured to substantially close the base structure when the lid is in a closed position on the base structure,
the lid being movable from the closed position to an open position to permit the introduction of an animal patient into the
base structure;

wherein the base structure or the lid has at least one open-ended slot which is partially obstructed when the lid is in the
closed position, and

wherein the base structure or the lid has at least one aperture which is not obstructed when the lid is in the closed position;
and

wherein the base structure comprises a base member having a semi-cylindrical configuration and wherein the lid has a semi-cylindrical
configuration, so that when the lid is in the closed position, the base member and the lid cooperate to define a substantially
cylindrical space;

wherein the base structure includes a footing for stably supporting the base member on a flat surface; and
wherein the enclosure is substantially X-ray transparent.

US Pat. No. 9,080,187

METHODS AND COMPOSITIONS FOR PRODUCING SOLVENTS

The Board of Trustees of ...

1. A method of producing butanol comprising contacting a carbohydrate-comprising substrate with recombinant Clostridia or Escherichia coli bacteria transformed with a nucleic acid that results in a decreased level or activity of ManIIAB polypeptide or ManIIC polypeptide
compared to the bacteria prior to transformation with a substrate, such that the substrate is metabolized to butanol.
US Pat. No. 9,549,928

MUSCARINIC AGONISTS AS ENHANCERS OF COGNITIVE FLEXIBILITY

THE UNIVERSITY OF TOLEDO,...

1. A method of improving a cognitive flexibility function in a human subject having a need thereof, comprising the steps of:
administering to the subject a composition that includes a therapeutically effective amount of at least one M1 agonist compound
without substantially producing M2, M3, M4 and/or M5 subtype receptor agonist activity;

wherein the M1 agonist compound is [5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine] (CDD-0102), or a pharmaceutically
acceptable salt or hydrate thereof; and

wherein the subject does not have a cholinergic deficit, and does have cognitive deficits not associated with a neurodegenerative
disorder; and,

improving the cognitive flexibility function in the subject.

US Pat. No. 9,506,858

OPTICAL PARAMETRIC AMPLIFICATION OF WEAK SIGNALS FOR IMAGING BIOLOGICAL TISSUE

The Board of Trustees of ...

1. A method for obtaining an image of scattering biological tissue, the method comprising:
a. generating a series of pulses of substantially monochromatic light of a first wavelength;
b. splitting each of the pulses into a first part and a second part;
c. converting the first part of each pulse into a white light supercontinuum;
d. illuminating the scattering biological tissue with the white light supercontinuum;
e. upconverting the second part of each pulse to a generate a pump beam;
f. collecting both ballistic and multiply scattered sample light from the biological tissue;
g. forming a virtual pinhole by directing both the ballistic and multiply scattered sample light from the scattering biological
tissue and the pump beam onto a non-linear optical element; and

h. selectively detecting parametrically amplified ballistic sample light emerging from the non-linear optical element.

US Pat. No. 9,442,285

OPTICAL COMPONENT ARRAY HAVING ADJUSTABLE CURVATURE

The Board of Trustees of ...

1. An imaging system comprising:
a deformable substrate having a contact surface, wherein said deformable substrate is an elastomeric membrane;
an array of mechanically interconnected optical components supported by said contact surface, wherein said optical components
comprise photodiodes that form a photodetector array;

an encapsulating layer supported by said deformable substrate, wherein the encapsulating layer at least partially encapsulates
said array of mechanically interconnected optical components;

an actuator operably connected to said contact surface, wherein said actuator is configured to continuously adjust a curvature
of said contact surface, wherein change of curvature by the actuator is reversible;

a dynamically tunable and adjustable curvature lens in optical communication with said photodetector array; and
a processor for calculating a Petzval surface of an object imaged by said dynamically tunable and adjustable curvature lens,
wherein said actuator is configured to generate curvature of said photodetector that substantially matches the calculated
Petzval surface,

thereby providing a dynamically tunable imaging system having a continuously adjustable zoom and correspondingly continuously
adjustable photodetector array surface curvature configured to match the Petzval surface formed by a change in curvature of
said dynamically tunable and adjustable curvature lens.

US Pat. No. 9,388,131

AUTOMATED SYNTHESIS OF SMALL MOLECULES USING CHIRAL, NON-RACEMIC BORONATES

The Board of Trustees of ...

1. A compound of formula (II):

wherein:
B is a boron atom having sp3 hybridization;

the carbon atom marked “*” is a chiral carbon atom of at least 90% enantiomeric excess;
R10 is selected from the group consisting of


R11 and each instance of R12 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl,
heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy; or R11 and any one instance of R12, or any two instances of R12, taken together, form a 3-10-membered ring;

X is halogen;
each instance of Z is independently selected from the group consisting of CH and N, provided that no more than two instances
of Z are N;

X? is selected from the group consisting of CR5R6, O, S, and NR7;

R1 and R2 are both hydrogen or identically selected (C1-C3)alkyl;

R5 and R6 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, (C1-C10)alkyl, cycloalkyl, aryl, aralkyl,
heteroaralkyl, alkoxyl, acyl, acyloxy, aryloxy, amino, and trialkylsilyloxy;

R7 and R30 are independently selected from the group consisting of hydrogen and (C1-C3)alkyl;

n is 0, 1, or 2;
p is 0, 1, or 2; and
q is 1 or 2.

US Pat. No. 9,330,500

INSERTING OBJECTS INTO CONTENT

The Board of Trustees of ...

1. A method implemented in one or more computing devices, the method comprising:
obtaining a single image of a scene;
generating, based on the single image of the scene, a 3D model of the scene;
generating, based on the single image of the scene and in the absence of other images of the scene, a light model including
3D light source locations, directions, and intensities for the scene;

correcting the light model by automatically refining the locations of light sources projected onto the 3D model of the scene,
the automatically refining including choosing light parameters by at least one of the one or more computing devices minimizing
an objective function that is based on a rendered image of the scene and the single image of the scene in the absence of other
images of the scene, the objective function being further based on applying a per-pixel weighting that places less emphasis
on pixels near the ground;

inserting one or more objects into the 3D model of the scene; and
modifying the appearance of the single image, based on both the corrected light model and the 3D model of the scene, producing
a modified image of the scene that depicts the scene as if the one or more objects were actually part of the scene.

US Pat. No. 9,314,322

DEVICE AND METHOD FOR MEASURING PRESSURE EXERTED ON A SURFACE

The Board of Trustees of ...

1. A method for treatment of urinary stress incontinence of a patient, the method comprising the steps of:
introducing a force or a pressure sensor system on a skin surface of the patient adjacent to the urethra of the patient at
a first time in a non-surgical clinical setting, wherein the force or pressure sensor system comprises a force or pressure
sensor;

applying an application force or pressure onto the force or the pressure sensor system and the underlying urethra in the non-surgical
clinical setting, wherein the application force or pressure is sufficient to temporarily alleviate a urinary stress incontinence
symptom and the force or pressure sensor is positioned between the application force or pressure and the urethra;

identifying a clinically-derived an alleviation output from the force or pressure sensor on the skin surface corresponding
to a minimum force or pressure sufficient to alleviate the urinary stress incontinence symptom in the non-surgical clinical
setting;

inserting a surgical sling to support the urethra in a surgical setting;
positioning the force or pressure sensor system to determine a force or pressure exerted by the surgical sling on the urethra
at a second time in the surgical setting, wherein the second time in the surgical setting is after the first time in the non-surgical
clinical setting;

exerting a force or pressure on the urethra by generating a force or pressure on the surgical sling in the surgical setting,
wherein the exerted force or pressure is detected by the force or pressure sensor; and

matching the exerted force or pressure on the urethra in the surgical setting to the clinically-derived alleviation output
in the non-surgical clinical setting, thereby obtaining selecting an optimal generated force or pressure by the surgical sling
in the surgical setting,

wherein the optimal generated force or pressure by the surgical sling in the surgical setting at the second time is within
about 20% of the clinically-derived alleviation output of the identifying step at the first time, thereby treating urinary
stress incontinence of the patient.

US Pat. No. 9,550,845

MULTIPLE STAGE CURABLE POLYMER WITH CONTROLLED TRANSITIONS

The Board of Trustees of ...

1. A polymer-formation system comprising a first composition and a second composition separated from one another, wherein
the first composition is different from the second composition, and the first and second compositions are stable in isolation
from each other, but react in the presence of each other; wherein
the first composition comprises a first gelator and the first gelator comprises a plurality of acylhydrazine moieties;
the second composition comprises a second gelator and the second gelator comprises a plurality of formyl moieties;
at least one of the first composition and the second composition comprises a prepolymer;
one of the first composition and the second composition comprises a gelation catalyst; and
when combined, the first composition and the second composition react with one another, resulting in the formation of a gel
prior to polymerization that results in a solid polymer.

US Pat. No. 9,404,909

METHOD AND APPARATUS FOR CONTROLLING MATERIALS THROUGH A THROUGH-HOLE

THE BOARD OF TRUSTEES OF ...

1. A method, comprising:
applying a first electrical potential to a membrane having a nanopore to repel a molecular strand from a top surface and a
bottom surface of the membrane, wherein the membrane and the molecular strand are placed in an electrolyte solution;

applying a second electrical potential to the electrolyte solution to apply a transport force on the molecular strand to displace
a section of the molecular strand into the nanopore;

arresting the section of the molecular strand in the nanopore by adjusting the first electrical potential to cause the molecular
strand to adhere to the top surface and the bottom surface of the membrane and by adjusting the second electrical potential
to reduce the transport force; and

measuring a signal at the nanopore to identify the section of the molecular strand.
US Pat. No. 9,182,399

VIRUS TRAPS

Christian-Albrechts-Unive...

1. A method for binding viral particles comprising contacting a viral particle comprising contacting a viral particle with
a particle or particle agglomerate comprising a metal oxide semiconductor surface and a plurality of polar defect sites, wherein
the surface of the surface to volume ratio of the particle or particle agglomerate is larger than that of a spherical particle
of the same volume, and wherein the largest cross sectional length of the particle or particle agglomerate ranges from about
100 nm to about 30 ?m, and wherein the particle or particle agglomerate does not significantly impair cell viability at concentrations
up to 500 ?g/ml.
US Pat. No. 9,050,180

MICROVASCULAR STAMP FOR PATTERNING OF FUNCTIONAL NEOVESSELS

The Board of Trustees of ...

1. A microvascular stamp comprising one or more types of cells encapsulated in a poly(ethylene glycol) diacrylate (PEGDA)
and methacrylic polymer cross-linked hydrogel, wherein the cross-linked hydrogel comprises microchannels, wherein neovessels
are localized within the lumina of the microchannels.

US Pat. No. 9,517,939

METHOD OF ENHANCING THE CONNECTIVITY OF A COLLOIDAL TEMPLATE, AND A HIGHLY INTERCONNECTED POROUS STRUCTURE

The Board of Trustees of ...

17. A method of forming a conductive porous structure, the method comprising:
forming a lattice of microparticles from a suspension of microparticles by self-assembly and drying, the microparticles of
the lattice being in contact with adjacent microparticles of the lattice at contact regions therebetween;

after forming the lattice of microparticles by self-assembly and drying, annealing the lattice to strengthen the contact between
adjacent microparticles, thereby forming an annealed lattice of microparticles;

after the annealing, exposing the annealed lattice to a solution comprising a solvent and a precursor material;
removing the solvent from the solution, the precursor material moving to the contact regions;
after removing the solvent, curing the precursor material to form a ring comprising a polymer around each of the contact regions,
thereby creating interconnects between adjacent microparticles of the annealed lattice and enhancing the connectivity of the
annealed lattice;

after forming the ring around each of the contact regions, infilling the annealed lattice with a conductive material, the
conductive material coating the microparticles of the annealed lattice and the interconnects;

after the infilling, removing the microparticles of the annealed lattice and the interconnects to obtain a monolithic porous
structure comprising the conductive material and including (a) voids defined by the microparticles and (b) necks between the
voids defined by the interconnects; and

after removing the microparticles, depositing an electrochemically active material on the monolithic porous structure, thereby
forming a porous battery electrode.

US Pat. No. 9,184,341

FLEXIBLE AND ON WAFER HYBRID PLASMA-SEMICONDUCTOR TRANSISTORS

The Board of Trustees of ...

1. A hybrid plasma semiconductor device, comprising base and emitter regions and a microcavity dimensioned to contain collector
plasma within a single thin active device layer.

US Pat. No. 9,090,667

CYCLIC PEPTIDE FROM NONOMURAEA SP., PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MYCOBACTERIA RELATED DISEASE COMPRISING THE SAME

Myongji University Indust...

1. A crystalline pharmaceutical composition for the prevention or treatment of a Mycobacterium spp. related disease comprising a compound of Formula 1 and/or Formula 2 as an active ingredient in association with a pharmaceutically
acceptable carrier, diluent, or excipient:

US Pat. No. 9,061,494

HIGH RESOLUTION ELECTROHYDRODYNAMIC JET PRINTING FOR MANUFACTURING SYSTEMS

The Board of Trustees of ...

1. An electrohydrodynamic printing system comprising:
a nozzle having an ejection orifice for dispensing a printing fluid;
a substrate having a surface facing said nozzle; and
a voltage source for applying an electric charge to said nozzle to cause said printing fluid to be controllably deposited
on said substrate surface in a balanced-jet printing mode, wherein said electric charge is applied at a frequency that oscillates
between a positive and negative electric potential during printing to reduce a net charge of printing fluid to said substrate
compared to printing without oscillation between the positive and negative electric potential;

wherein said ejection orifice has an ejection area that is less than 700 ?m2 and said printing fluid controllably deposited on said substrate has a print resolution that is between 100 nm and 10 ?m.

US Pat. No. 9,611,266

COMPOUNDS AND ANTI-TUMOR NQO1 SUBSTRATES

The Board of Trustees of ...

1. A compound of the Formula (I):

wherein
R1 is alkyl;

R3 is H;

R2 and R4 are each independently —X—R;

each X is independently a direct bond, —C(?O)—, or (C1-C20)alkyl;

each R is independently alkyl, alkenyl, alkynyl, heteroalkyl, cycloalkyl, (cycloalkyl)heteroalkyl, aryl, heteroaryl, alkoxy,
(alkoxy)alkyl, or saccharide;

wherein any alkyl or aryl can be optionally substituted with one or more hydroxy, amino, cyano, nitro, or halo groups;
provided that R1, R2, and R4 are not each methyl;

or a salt or solvate thereof
provided that when R1, R2, and R3 are methyl, R4 is not H or methyl; and provided that when R1, R3, and R4 are methyl, the group —X—R of R2 is not acyloxy.

US Pat. No. 9,561,286

STERICALLY STABILIZED CATIONIC NANOCARRIER, KITS AND METHOD OF USE

THE BOARD OF TRUSTEES OF ...

1. A sterically stabilized nanocarrier comprising a PEGylated phospholipid complexed with one or more cationic phospholipids,
wherein said sterically stabilized nanocarrier has a particle size of about 10 nm to about 100 nm and the cationic phospholipid
has the structure of Formula I:

wherein R is a linear chain of between 1 and 10 basic amino acid residues and each R1 is independently a saturated or unsaturated acyl chain of between 16 and 18 carbon atoms.

US Pat. No. 9,379,640

SCALABLE SINGLE-STAGE DIFFERENTIAL POWER CONVERTER

The Board of Trustees of ...

1. A single-stage DC/AC power converter, comprising:
at least two bi-directional converter modules connected in differential configuration, each of said two bi-directional converter
modules having primary and secondary sides separated by transformers and including inductors for current flow and energy storage,
wherein each of the two bi-directional converter modules comprises transformers and inductors that are integrated on one or
more cores;

switches controlling current flow in the primary and secondary sides to create positive and negative half cycle AC current
to an output on said secondary side from a DC power source on said primary side or controlling current flow in the primary
and secondary sides to create AC output on said primary/secondary side from an AC power source on said secondary/primary side;

a loop controller having an outer voltage loop and an inner current loop with a first modulator that controls modulation of
said switches via a second modulator referenced by said inner current loop, wherein one or both of said outer voltage loop
and said inner current loop include a fundamental frequency compensator and a plurality of harmonic frequency compensators,
and further including different fundamental and harmonic voltage loop references for outer loop control.

US Pat. No. 9,241,958

ANTICOAGULANT ANTAGONIST AND HEMOPHILIA PROCOAGULANT

The Board of Trustees of ...

1. A method of reducing the effects of an anticoagulant drug on a patient, comprising administering an amount of a polyphosphate
(polyP) to a patient who has been administered the anticoagulant drug, wherein the polyP is polyPn and n is at least 25, and wherein the polyP reduces the clotting time of plasma or whole blood of the patient containing the
anticoagulant drug.

US Pat. No. 9,588,327

NANOINDENTER MULTIMODAL MICROSCOPE OBJECTIVE FOR MECHANOBIOLOGY

The Board of Trustees of ...

1. A method for characterizing a sample in situ, the method comprising:
a. applying a force, by means of a nanoprobe, disposed within an umbral zone occluded by a secondary mirror of a reflective
microscope objective and centered upon a probed locus on the surface of a sample;

b. focusing light with the reflective microscope objective onto a region of the sample including the said probed locus on
the surface of the sample;

c. measuring a mechanical response of the sample to the applied force; and
d. imaging the region of the sample including the probed locus, concurrently with measuring the mechanical response of the
sample.

US Pat. No. 9,487,002

HIGH RESOLUTION ELECTROHYDRODYNAMIC JET PRINTING FOR MANUFACTURING SYSTEMS

The Board of Trustees of ...

1. A method of depositing a feature onto a substrate surface comprising the steps of:
providing an electrohydrodynamic printing system comprising:
a nozzle having an ejection orifice for dispensing a printing fluid, wherein said ejection orifice has an ejection area that
is less than 700 ?m2;

a substrate having a surface facing said nozzle;
a voltage source for applying an electric charge to said nozzle to cause said printing fluid to be controllably deposited
on said substrate surface;

providing said printing fluid to said nozzle; and
applying an electrical charge to said printing fluid in said nozzle thereby establishing an electrostatic force capable of
ejecting said printing fluid from said nozzle onto said surface to generate a feature on said substrate in a balanced mode
that oscillates between a positive and a negative electric potential to reduce a net charge of printing fluid to said substrate
compared to printing without oscillation between the positive and negative electric potential, and said method has a print
resolution that is between 100 nm and 10 ?m.

US Pat. No. 9,475,791

COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS

THE BOARD OF TRUSTEES OF ...

1. A compound having formula (I-vii)

wherein
R1 is selected from the group consisting of hydrogen, alkyl, —SO3Rx1, —PO3Ry1Rz1, and —C(?O)Ra;

R2 is selected from the group consisting of halo and —OR3;

R3 is selected from the group consisting of hydrogen, alkyl, —SO3Rx1, —PO3Ry1Rz1, and —C(?O)Ra;

R4 is selected from the group consisting of hydrogen, alkyl, —SO3Rx1, —PO3Ry1Rz1, and —C(?O)Ra;

Ra, at each occurrence, is independently selected from the group consisting of —OH and alkyl; and

Rx1, Ry1 and Rz1 are, at each occurrence, independently selected from the group consisting of hydrogen and a pharmaceutically acceptable cation.

US Pat. No. 9,406,938

THREE-DIMENSIONAL (3D) POROUS ELECTRODE ARCHITECTURE FOR A MICROBATTERY

The Board of Trustees of ...

1. A method of fabricating a three-dimensional porous electrode architecture for a microbattery, the method comprising:
providing a surface comprising a first conductive pattern and a second conductive pattern thereon, the first and second conductive
patterns being electrically isolated from each other;

forming a lattice structure on the surface;
infiltrating interstices of the lattice structure with a first conductive material and a second conductive material, the first
and second conductive materials propagating through the interstices in a direction away from the surface to reach a predetermined
thickness, where the first conductive material spans an area of the surface overlaid by the first conductive pattern and the
second conductive material spans an area of the surface overlaid by the second conductive pattern;

removing the lattice structure to form a network of interconnected voids in each of the first and second conductive materials,
thereby forming three-dimensional first and second conductive scaffolds, each conductive scaffold having the predetermined
thickness and a lateral size and shape defined by the respective conductive pattern;

conformally depositing an anode active material on the second conductive scaffold to form a porous anode; and
after depositing the anode active material, conformally depositing a cathode active material on the first conductive scaffold
to form a porous cathode, and

lithiating the porous cathode,
thereby forming a three-dimensional battery electrode architecture.

US Pat. No. 9,330,877

LOGIC FUNCTION GENERATION FROM SINGLE MICROPLASMA TRANSISTOR DEVICES AND ARRAYS OF DEVICES

The Board of Trustees of ...

1. A method for providing a logic function with a single microplasma transistor device, the method comprising:
generating a microplasma within a microcavity in proximity to a solid state semiconductor pn junction; and
with one of a plurality of microplasmas forming sub-collectors with a common emitter, or a common collector plasma with a
plurality of sub-emitter regions in the solid state semi-conductor pn-junction, generating a logic output from an electrode
based upon electrode inputs to two other electrodes.

US Pat. No. 9,255,791

OPTICALLY MONITORING AND CONTROLLING NANOSCALE TOPOGRAPHY

The Board of Trustees of ...

1. A method for characterizing a height profile of a scattering surface of arbitrary profile relative to a fiducial plane,
the method comprising:
a. illuminating the scattering surface with substantially spatially coherent light;
b. collecting light scattered by the scattering surface;
c. providing a blazed diffraction grating disposed within an image plane of a microscope, the blazed grating adapted to create
multiple copies of an image of the scattering surface of arbitrary profile, with one copy of the image in each diffraction
order and with power maximized in a first diffraction order;

d. dispersing the scattered light by means of the blazed diffraction grating into zeroth- and first-order beams;
e. creating a spatial Fourier transform of the zeroth- and first-order beams;
f. low-pass filtering one of the zeroth and first-order beams in a Fourier plane, thereby forming a reference beam of a Mach-Zehnder
interferometer;

g. interfering the zeroth- and first-order beams at a focal plane detector to generate an interferogram; and
h. transforming the interferogram to retrieve at least one of a spatially resolved quantitative phase image and an amplitude
image of the scattering surface.

US Pat. No. 9,250,113

CELL MASS MEASUREMENT AND APPARATUS

The Board of Trustees of ...

1. A resonant mass sensor comprising a microfabricated suspended platform having a measuring surface congruent with the suspended
platform and comprising at least four sides, wherein each side opposibly faces another side,
wherein the suspended platform is supported by at least four tethers, wherein each side is connected to at least one of the
at least four tethers that is not connected to another side to accommodate vertical displacement of the suspended platform,

each tether having a folded geometry comprising a flexural portion and a torsional portion,
and wherein a resonant oscillation of the suspended platform exhibits a uniform vibration amplitude that varies by less than
3% across the entire measuring surface.

US Pat. No. 9,105,782

ARRAYS OF ULTRATHIN SILICON SOLAR MICROCELLS

The Board of Trustees of ...

1. A conformal solar cell device comprising:
a plurality of composite solar microcells, each composite solar microcell comprising:
a flexible substrate;
a flexible semiconductor element disposed on the flexible substrate, the flexible semiconductor element comprising at least
one active region; and

an encapsulant material disposed over a portion of the flexible semiconductor element; and
one or more flexible interconnects;wherein each of the one or more flexible interconnects is in electrical communication with a portion of each flexible semiconductor
element of at least two adjacent composite solar microcells; andwherein the flexible semiconductor element of at least one composite solar microcell of the plurality of composite solar microcells
has a thickness less than or equal to about 100 ?m and includes an active region comprising solar-grade silicon or low-grade
silicon.

US Pat. No. 10,143,086

TRANSIENT ELECTRONIC DEVICES COMPRISING INORGANIC OR HYBRID INORGANIC AND ORGANIC SUBSTRATES AND ENCAPSULATES

The Board of Trustees of ...

1. A method of using a transient electronic device, said method comprising the steps of:providing the transient electronic device comprising:
a substrate;
one or more active or passive electronic device components supported by said substrate; wherein said active or passive electronic device components independently comprise a selectively transformable material; and
an encapsulant layer at least partially encapsulating said one or more active or passive electronic device components;
wherein said substrate, said encapsulant layer or both independently comprise a selectively removable inorganic material responsive to an external or internal stimulus; wherein at least partial removal of said substrate, said encapsulant layer or both in response to said external or internal stimulus initiates at least partial transformation of said one or more active or passive electronic device components providing a programmable transformation of the transient electronic device in response to said external or internal stimulus at a pre-selected time or at a pre-selected rate, wherein said programmable transformation provides a change in function of the transient electronic device from a first condition to a second condition; and
exposing said transient electronic device to said external or internal stimulus resulting in said at least partial removal of said substrate or encapsulant layer to expose said one or more active or passive electronic device components to said external or internal stimulus, thereby providing said programmable transformation of the transient electronic device;
wherein said removal of said substrate, said encapsulant layer or both in response to said internal or external stimulus occurs via a phase change, dissolution, hydrolysis, bioresorption, etching, corrosion, a photochemical reaction, an electrochemical reaction or any combination of these processes.

US Pat. No. 10,064,269

STRETCHABLE AND FOLDABLE ELECTRONIC DEVICES

The Board of Trustees of ...

1. A method of making a stretchable and foldable electronic device, said method comprising:coating a receiving substrate having a first Young's modulus with an isolation layer having a second Young's modulus, said isolation layer having a receiving surface, wherein said second Young's modulus is less than said first Young's modulus;
at least partially supporting an electronic device on said isolation layer receiving surface;
encapsulating at least a portion of said electronic device in an encapsulation layer; and
wherein said isolation layer isolates at least a portion of said electronic device from an applied strain.

US Pat. No. 9,561,488

PROCESS FOR PRODUCING A REGENERABLE OXIDE-BASED ADSORBENT

The Board of Trustees of ...

1. A process for producing a zinc titanate reactive adsorbent comprising electrospinning a solution, the solution comprising
an organic zinc-containing compound and a titanium-containing compound wherein the organic zinc-containing compound comprises
zinc acetate dihydrate and the titanium-containing compound comprises titanium (IV) isopropoxide,
wherein the zinc titanate adsorbent comprises multiphase, polycrystalline nanofibers comprising ZnTiO3, ZnO, TiO2, and Zn2TiO4, and having a diameter ranging from 350 to 800 nm.

US Pat. No. 9,496,229

TRANSIENT ELECTRONIC DEVICES COMPRISING INORGANIC OR HYBRID INORGANIC AND ORGANIC SUBSTRATES AND ENCAPSULATES

The Board of Trustees of ...

1. A transient electronic device comprising:
a substrate;
one or more active or passive electronic device components supported by said substrate; wherein said active or passive electronic
device components independently comprise a selectively transformable material; and

an encapsulant layer at least partially encapsulating said one or more active or passive electronic device components;
wherein said substrate, said encapsulant layer or both independently comprise a selectively removable inorganic material responsive
to an external or internal stimulus; wherein at least partial removal of said substrate, said encapsulant layer or both in
response to said external or internal stimulus initiates at least partial transformation of said one or more active or passive
electronic device components providing a programmable transformation of the transient electronic device in response to said
external or internal stimulus at a pre-selected time or at a pre-selected rate, wherein said programmable transformation provides
a change in function of the transient electronic device from a first condition to a second condition.

US Pat. No. 9,464,113

ANTI-HEPARAN SULFATE PEPTIDES THAT BLOCK HERPES SIMPLEX VIRUS INFECTION IN VIVO

The Board of Trustees of ...

1. A peptide comprising at least 10 consecutive amino acids of the sequence XXRRRRXRRRXK (SEQ ID NO: 4) or KXRRRXRRRRXX (SEQ
ID NO: 10) wherein X is any amino acid, R is arginine, and K is lysine, wherein the peptide is no more than 12 amino acids
long, and wherein at least one of the at least 10 amino acids is a D-amino acid.

US Pat. No. 9,045,933

ENERGY-EFFICIENT SMART WINDOW SYSTEM

The Board of Trustees of ...

1. A method of spatially separating visible and near-infrared electromagnetic radiation, the method comprising the steps of:
providing a first blazed diffraction grating, said first blazed diffraction grating having a first blaze direction, a first
grating pitch and a first blaze angle;

providing a second blazed diffraction grating positioned in optical communication with said first blazed diffraction grating,
said second blazed diffraction grating having a second blaze direction, a second grating pitch and a second blaze angle, and
wherein said first grating pitch and said second grating pitch are different, wherein said first blaze angle and said second
blaze angle are different and wherein said second blaze direction is oriented opposite to said first blaze direction;

passing visible electromagnetic radiation and near-infrared electromagnetic radiation through said first blazed diffraction
grating, wherein at least a portion of said visible electromagnetic radiation is diffracted by said first blazed diffraction
grating in a first diffraction direction and a majority of said near-infrared electromagnetic radiation is not diffracted
by said first blazed diffraction grating, thereby generating diffracted visible electromagnetic radiation and non-diffracted
near-infrared electromagnetic radiation;

passing said diffracted visible electromagnetic radiation and said non-diffracted near-infrared electromagnetic radiation
through said second blazed diffraction grating, wherein at least a portion of said non-diffracted near-infrared electromagnetic
radiation is diffracted by said second blazed diffraction grating in a second diffraction direction, thereby generating diffracted
near-infrared electromagnetic radiation;

wherein said first diffraction direction is different from said second diffraction direction, thereby spatially separating
said visible electromagnetic radiation and said near-infrared electromagnetic radiation.

US Pat. No. 9,601,234

THREE-DIMENSIONAL (3D) POROUS DEVICE AND METHOD OF MAKING A 3D POROUS DEVICE

The Board of Trustees of ...

1. A method of making a three-dimensional porous micromechanical device, the method comprising:
providing a substrate having a conductive pattern on a surface thereof, the substrate comprising a patterned portion of the
surface covered by the conductive pattern and an unpatterned portion of the surface not covered by the conductive pattern;

after providing the substrate, depositing a colloidal solution comprising a plurality of microparticles onto the surface of
the substrate, the microparticles assembling into a lattice structure on the patterned and unpatterned portions of the surface;

infiltrating interstices of the lattice structure with a conductive material, the conductive material propagating through
the interstices in a direction away from the substrate to reach a predetermined thickness and spanning an area of the surface
overlaid by the conductive pattern;

removing the microparticles to form voids in the conductive material, thereby forming a conductive porous structure having
the predetermined thickness and a lateral size and shape of the conductive pattern, and

removing only a portion of the substrate to expose an underside of the conductive pattern,
thereby forming the three-dimensional porous micromechanical device.

US Pat. No. 9,515,025

STRETCHABLE FORM OF SINGLE CRYSTAL SILICON FOR HIGH PERFORMANCE ELECTRONICS ON RUBBER SUBSTRATES

The Board of Trustees of ...

1. A two-dimensionally stretchable electronic device comprising:
a flexible substrate having a supporting surface; and
a semiconductor structure supported by said supporting surface and having a spatially-varying contour profile that varies
in at least two lateral spatial dimensions relative to the supporting surface, wherein the semiconductor structure is discontinuously
bonded to said supporting surface; and

wherein the contour profile varying in at least two spatial dimensions accommodates stretching, compressing, and/or flexing
in more than one direction without device failure.

US Pat. No. 9,433,943

THERMAL CONTROL OF DROPLETS BY NANOSCALE FIELD EFFECT TRANSISTORS

The Board of Trustees of ...

1. A method of selectively heating a fluid droplet, the method comprising the steps of:
providing a nano-heater transistor having a receiving surface, wherein the nano-heater transistor comprises a field effect
transistor;

introducing a fluid droplet to the receiving surface, the fluid droplet having a droplet volume that is less than 10 nL;
surrounding the fluid droplet exposed surface with a gas phase atmosphere;
heating the nano-heater by applying an AC voltage to the field effect transistor to selectively heat a fluid droplet interior
portion to a fluid droplet maximum temperature without substantially heating the gas phase atmosphere that surrounds the fluid
droplet,

wherein the gas phase atmosphere has a gas phase average temperature and the fluid droplet has an outermost layer having a
thickness selected from a range that is between 1 ?m and 10 ?m with a fluid droplet minimum temperature, and the minimum fluid
droplet temperature is within 10% of the gas phase average temperature and the fluid droplet maximum temperature is more than
100% different than the minimum fluid droplet temperature;

thereby selectively heating the fluid droplet.

US Pat. No. 9,230,063

AUTOMATED PROSTATE TISSUE REFERENCING FOR CANCER DETECTION AND DIAGNOSIS

THE BOARD OF TRUSTEES OF ...

1. A method comprising:
obtaining, by a processor, a Hematoxylin and Eosin (HE) stained image of a test prostate sample;
obtaining, by the processor, an Infrared (IR) image of the test prostate sample;
performing segmentation, by the processor, for the test prostate sample utilizing the HE stained image and the IR image;
identifying, by the processor, epithelial cells, epithelial nuclei and lumens in the test prostate sample according to the
segmentation;

selecting, by the processor, a group of morphological features from a plurality of morphological features associated with
the epithelial cells, the epithelial nuclei and the lumens of the test prostate sample;

determining the group of morphological features for the epithelial cells, the epithelial nuclei and the lumens in the test
prostate sample based on an analysis of at least the HE stained image;

performing, by the processor, a comparison of the group of morphological features for the test prostate sample with reference
sample information stored in a database, wherein the reference sample information represents reference morphological features
for reference prostate samples, wherein the reference prostate samples are identified in the database by a confirmed pathological
status;

selecting, by the processor, a group of reference prostate samples from the reference prostate samples according to the comparison;
and

presenting, by the processor, reference data for the group of reference prostate samples.

US Pat. No. 9,185,200

SMARTPHONE BIOSENSOR

The Board of Trustees of ...

1. A system, comprising:
a mobile computing device, wherein the mobile computing device includes an image sensor, a processor, and a memory that stores
program instructions;

an optical instrument, comprising:
a sample chamber for receiving an optical assay medium configured to perform a biomolecular assay, wherein the sample chamber
comprises a door that prevents stray light from entering, wherein the optical assay medium comprises at least one fluorophore;

a light source;
an input optical path for directing light from the light source to the optical assay medium in the sample chamber, wherein
the input optical path comprises a first multimode fiber;

an output optical path for receiving an optical output from the optical assay medium in the sample chamber, wherein the output
optical path comprises a second multimode fiber and a wavelength-dispersive element configured to disperse the optical output
into spatially-separated wavelength components; and

a mount for mounting the mobile computing device to the instrument in a fixed position relative to the wavelength-dispersive
element, wherein in the fixed position the image sensor of the mobile computing device is optically coupled to the output
optical path such that the image sensor receives at least a portion of the dispersed optical output and different wavelength
components are received at different locations on the image sensor, wherein the program instructions stored in the memory
are executable by the processor to cause the mobile computing device to perform functions, the functions comprising:

using the image sensor to obtain at least one image of the portion of the dispersed optical output; and
determining a wavelength spectrum of the optical output based on the at least one image.

US Pat. No. 9,143,053

MICROINVERTERS FOR EMPLOYMENT IN CONNECTION WITH PHOTOVOLTAIC MODULES

Sandia Corporation, Albu...

20. A solar power system installation, comprising:
a photovoltaic module, the photovoltaic module comprising:
a first MEPV cell that outputs first direct current output responsive to receiving solar radiation;
a first microinverter that is coupled to the first MEPV cell, the first microinverter configured to convert the first direct
current output to first three-phase alternating current output;

a second MEPV cell that outputs second direct current output responsive to receiving solar radiation; and
a second microinverter that is coupled to the second MEPV cell, the second microinverter configured to convert the second
direct current output to second three-phase alternating current, wherein the first microinverter is electrically connected
in parallel with the second microinverter, and wherein the first microinverter and the second microinverter are configured
to respectively output the first alternating current output and the second alternating current output in an interleaved fashion.


US Pat. No. 9,101,726

STEM CELL IMMUNE MODULATION METHODS OF USE AND APPARATUS

The Board of Trustees of ...

1. A bioreactor for modulating lymphocytes and suppressing autoreactive T cells, comprising:
a chamber having at least one positively charged and hydrophobic substrate surface;
a population of stem cells attached to the substrate surface, wherein the stem cells are characterized by: (a) displaying
embryonic stem cell characteristics; (b) displaying hematopoietic cell characteristics as being positive for leukocyte common
antigen CD45; (c) not expressing the CD34 marker; (d) displaying low immunogenicity; and (e) expressing autoimmune regulator;

an inlet conduit for introducing lymphocytes into the chamber for co-culturing with the stem cells, and the lymphocytes are
free from plasma before being introduced into the chamber; and

an outlet conduit for extracting the lymphocytes following co-culturing with the stem cells.

US Pat. No. 9,075,935

MERIT-BASED CHARACTERIZATION OF ASSERTIONS IN HARDWARE DESIGN VERIFICATION

The Board of Trustees of ...

1. A method comprising:
generating, using a processor and memory of a computing device, assertions for verification of an integrated circuit hardware
design expressed at a register transfer level (RTL) for variables of interest within the design, each assertion including
variables of an antecedent related to respective target variables of a consequent;

determining, using the processor and for an assertion, a relative importance score for a variable comprising characterizing
the variable by a level of importance with respect to a target variable of the consequent;

computing, using the processor, a relative importance score of the assertion from the relative importance scores of the variables
of the assertion;

determining, using the processor, a relative complexity score for the variable comprising characterizing the variable by a
level of understandability of the variable with respect to the target variable;

computing, using the processor, a relative complexity score of the assertion from the relative complexity scores of the variables
of the assertion; and

ranking, using the processor, the assertion with respect to the RTL design for which the assertion was generated by combining
the relative importance and complexity scores of the assertion, thus indicating to a designer a relative value of the assertion
in performing the verification.

US Pat. No. 9,052,180

SPATIAL LIGHT INTERFERENCE TOMOGRAPHY

The Board of Trustees of ...

1. A method for deriving a quantitative phase contrast tomographic image of a specimen, the method comprising steps of:
a. illuminating the specimen with illuminating light characterized by a coherence length substantially shorter than a dimension
of a feature of the specimen to be resolved;

b. scanning a focus of the illuminating light to a plurality of depths within the specimen;
c. spatially Fourier transforming light transmitted through the specimen at each of the plurality of depths to form a spatially
Fourier transformed image;

d. spatially modulating at least one of the phase and amplitude of a plurality of spatial frequency components of the spatially
Fourier transformed image;

e. detecting an intensity image of the specimen plane as modulated with respect to spatial frequency components and as interfered
with an unscattered component of the illuminating light;

f. deconvolving the intensity image at a plurality of spatially modulated instances to obtain a three-dimensionally registered
phase representation of light scattered by the specimen at each of the plurality of distances relative to a fiducial plane;
and

g. solving for a quantitative phase contrast tomographic image of the specimen by an inverse scattering solution, by iterative
search for a point spread function entirely in a spectral domain and subject to a regularization parameter, based on a linear
forward model of scattering through an imaging system.

US Pat. No. 9,613,911

SELF-SIMILAR AND FRACTAL DESIGN FOR STRETCHABLE ELECTRONICS

The Board of Trustees of ...

54. An electronic circuit comprising:
an elastic substrate; and
a stretchable metallic or semiconducting device component supported by said elastic substrate; said stretchable metallic or
semiconducting device component comprising a plurality of electrically conductive elements each having a primary unit cell
shape, said electrically conductive elements connected in a sequence having a secondary shape providing an overall two-dimensional
spatial geometry characterized by a plurality of spatial frequencies; wherein said two-dimensional spatial geometry is a self-similar
two-dimensional geometry;

wherein said two-dimensional spatial geometry of said stretchable metallic or semiconducting device component allows for accommodation
of elastic strain along one or more in-plane or out of plane dimensions, thereby providing stretchability of said electronic
circuit.

US Pat. No. 9,478,713

NANOSTRUCTURE MATERIAL METHODS AND DEVICES

Rohm and Haas Electronic ...

1. A structure comprising:
a substrate having a first surface and a second surface; and
a polymeric layer disposed on the first surface of the substrate, the polymeric layer comprising a polymer and a plurality
of light-emitting nanocrystals;

the polymeric layer having a patterned surface, the patterned surface having a patterned first region having a first plurality
of recesses and a patterned second region having a second plurality of recesses, wherein the plurality of recesses in each
region has a first periodicity in a first direction, and a second periodicity in a second direction which intersects the first
direction, wherein the first periodicity of the first region is different from the first periodicity of the second region.

US Pat. No. 9,469,773

INK COMPOSITION FOR MAKING A CONDUCTIVE SILVER STRUCTURE

The Board of Trustees of ...

1. An ink composition for making a conductive silver structure, the ink composition comprising:
a silver salt; and
a complex of (a) a complexing agent and a short chain carboxylic acid, or (b) a complexing agent and a salt of a short chain
carboxylic acid.

US Pat. No. 9,457,101

HYDROGELS FOR DELIVERY OF THERAPEUTIC POLYPEPTIDES

The Board of Trustees of ...

1. A hydrogel composition for in vivo drug delivery comprising:
a polymer covalently linked to glutathione (GSH) with therapeutic polypeptide molecules bound to the hydrogel by glutathione
S-transferase (GST) fusion partners.

US Pat. No. 9,375,790

CONTINUOUS FLOW REACTOR AND METHOD FOR NANOPARTICLE SYNTHESIS

The Board of Trustees of ...

1. A continuous flow method for nanoparticle synthesis, the method comprising:
flowing a growth solution and a reaction-initiating solution into a mixing portion of a flow reactor to form a mixed solution,
the flow rate of each of the growth solution and the reaction-initiating solution into the mixing portion being at least about
15 mL/min;

flowing the mixed solution through a holding portion of the flow reactor for a predetermined residence time to form a reacted
solution comprising nanoparticles; and

continuously removing the reacted solution from the flow reactor so as to achieve a throughput of nanoparticles of at least
about 0.5 mg/min.

US Pat. No. 9,225,601

NETWORK-WIDE VERIFICATION OF INVARIANTS

The Board of Trustees of ...

1. A network-wide verification system comprising:
a network device interface to read and write packet-forwarding rules of varied, multiple network devices comprising switches
and routers of a network;

a controller in network communication with the multiple network devices via the interface and to:
obtain data comprising routing activity received from the multiple network devices of the network; and
transmit packet-forwarding rules in real time to the network devices;
computer storage in which are stored multiple network invariants expected to be upheld in valid network operations as determined
by a combined effect of packet-forwarding rules across multiple network devices; and

a data plane verification layer positioned between the network device interface and the controller and comprising non-transitory
computer-readable storage medium storing instructions that, when executed by at least one processing device, are to:

monitor packet-forwarding rule modifications in the network, including modifications initiated by the multiple network devices
and by the controller; and

verify validity of invariants of the network according to the stored multiple network invariants and the routing activity,
to perform verification of the invariants on parts of the network capable of being influenced by a new rule modification.

US Pat. No. 9,057,994

HIGH RESOLUTION PRINTING OF CHARGE

The Board of Trustees of ...

1. A method of printing a pattern of charge on a substrate surface, said method comprising the steps of:
providing a nozzle containing a printable fluid comprising a net charge suspended in a suspending fluid;
providing a substrate having a substrate surface;
generating from the nozzle an ejected printable fluid containing suspending fluid and net charge;
directing the ejected printable fluid containing net charge to the substrate surface, wherein the net charge does not substantially
degrade and the suspending fluid evaporates so that there is minimal transfer of the suspending fluid to the substrate; and

retaining the net charge on the substrate surface, thereby printing a pattern of charge on the substrate surface;
wherein the printed pattern of charge comprises a plurality of dots of charge that form nanolines having a width less than
100 nm and a length greater than or equal to 1 ?M.

US Pat. No. 9,559,349

METHOD OF FABRICATING A THREE-DIMENSIONAL (3D) POROUS ELECTRODE ARCHITECTURE FOR A MICROBATTERY

The Board of Trustees of ...

1. A method of fabricating a three-dimensional (3D) porous electrode architecture for a microbattery, the method comprising:
forming a microbattery template comprising:
a lattice structure comprising a first lattice portion separated from a second lattice portion on a substrate; and
a solid structure on the substrate at least partly surrounding the first and second lattice portions, the solid structure
comprising a separating portion disposed between the first and second lattice portions;

infiltrating interstices of the first lattice portion with a first conductive material and infiltrating interstices of the
second lattice portion with a second conductive material, each of the first and second conductive materials filling the interstices
to reach a predetermined thickness on the substrate;

removing the solid structure and the lattice structure from the substrate, thereby forming first and second conductive scaffolds
from the first and second conductive materials, the first and second conductive scaffolds comprising a porosity defined by
the lattice structure and having a lateral size and shape defined by walls of the solid structure.

US Pat. No. 9,167,970

NON-INVASIVE OPTICAL IMAGING FOR MEASURING PULSE AND ARTERIAL ELASTICITY IN THE BRAIN

The Board of Trustees of ...

1. An imaging system comprising:
an illumination system configured to illuminate a region of interest (ROI) of a brain of a subject under test (SUT), the ROI
having at least one blood vessel, and a reference blood vessel with photons and receive the photons after interaction with
the ROI and the reference blood vessel;

a light detection mechanism including an optical detector and a signal processing section, the light detection mechanism configured
to acquire the photons after interaction thereof with the ROI and the reference blood vessel to compile first imaging data
representing the ROI and second imaging data representing the reference blood vessel;

a processor, in operable communication with the light detection mechanism, configured to process the first and second imaging
data to determine a first shape parameter of a hemodynamic pulse in the at least one blood vessel and a second shape parameter
of a hemodynamic pulse in the reference blood vessel;

a display section, in which appears a display of at least one image representing the first shape parameter of a hemodynamic
pulse in the at least one blood vessel;
and
tangible, non-transitory storage medium containing program code which, when downloaded on said processor, causes the processor
to determine the first shape parameter from processing of the first imaging data;
to determine the second shape parameter based on processing of the second imaging data;
to compare said first and second shape parameters to determine a difference therebetween;
to transform the first imaging data to create said at least one image showing a distribution of the first shape parameter
in a cross-section of the ROI;

and
to form output data representing elasticity of said at least one blood vessel from the ROI based on said difference and said
at least one image.

US Pat. No. 9,161,989

CUPREDOXIN DERIVED TRANSPORT AGENTS AND METHODS OF USE THEREOF

The Board of Trustees of ...

1. A method comprising:
treating a cancer patient by administering a composition comprising a therapeutically effective amount of a peptide; and
a pharmaceutically acceptable carrier;
wherein the peptide consists of a sequence that has at least about 90% amino acid sequence identity to less than a full-length
wild-type cupredoxin or H.8 outer membrane protein and that has been modified to extend or optimize the half-life of the peptide
in the bloodstream of the cancer patient, and

wherein the peptide facilitates the entry of a linked molecule into a mammalian cancer cell.

US Pat. No. 10,154,592

MATERIALS, ELECTRONIC SYSTEMS AND MODES FOR ACTIVE AND PASSIVE TRANSIENCE

The Board of Trustees of ...

1. A transient electronic device comprising:a substrate; and
one or more active or passive electronic device components supported by said substrate, wherein said one or more active or passive electronic device components independently comprise a selectively transformable material;
wherein at least partial transformation of said one or more active or passive electronic device components provides a programmable transformation of the transient electronic device in response to an external or internal stimulus and at a pre-selected time or at a pre-selected rate, wherein said programmable transformation provides a change in function of the transient electronic device from a first condition to a second condition;
wherein said one or more active or passive electronic device components are independently characterized by an electrical dissolution rate (EDR) higher than a corrosion rate of said selectively transformable material, and wherein said EDR is selected to provide a pre-selected transience profile in response to said external or internal stimulus.
US Pat. No. 9,823,260

METHOD TO INCREASE BIOAVAILABILITY OF THE DELTA-OPIOID RECEPTOR FOR MANAGEMENT OF PAIN AND NEUROPSYCHIATRIC DISORDERS

Carnegie Mellon Universit...

1. A method of increasing bioavailability of delta-opioid receptors on a cell, comprising:
regulating phosphorylation of a phospholipid in a cell by administering a drug affecting a phosphatase or a phospholipid to
prevent intracellular retention of delta opioid receptors, wherein the drug is selected from the group consisting of bpV(phen),
bpV(HOptic), and SF1670;

thereby forcing delivery of the delta-opioid receptors to a surface of the cell.
US Pat. No. 9,624,517

PRODUCTION OF XYLITOL FROM A MIXTURE OF HEMICELLULOSIC SUGARS

The Board of Trustees of ...

1. An Escherichia coli microorganism capable of converting a mixture of hemicellulosic sugars, wherein the sugars are selected from the group consisting
of xylose, arabinose and combinations thereof, wherein the mixture of hemicellulosic sugars have a xylose:arabinose ratio
of approximately 3:1 or better, wherein the microorganism comprises:
(a) a mutant xylose reductase (XR), wherein the mutant xylose reductase comprises SEQ ID NO:20; wherein the mutant XR has
a higher selectivity for xylose than arabinose, and

(b) an inactivated glucose-specific phosphotransferase transport system gene (PtsG), or a cyclic adenosine monophosphate receptor
gene (CRP) mutation that de-represses xylose metabolism under aerobic conditions; and

(c) optionally, a D-xylose transporter gene (xylE) under the control of an araBAD promoter;
wherein there is near complete depletion of arabinose, and wherein conversion is by fermentation to xylitol with little or
no arabitol present in the final fermentation broth.

US Pat. No. 9,598,404

DEOXYCYTIDINE KINASE INHIBITORS

THE REGENTS OF THE UNIVER...

1. A compound having the formula:
wherein:
Y is C(R8) or N;

Z is C(R9) or N;

X is CH2, O, N(R10), S, S(O) or S(O)2;

R1 is hydrogen, halogen, —N3, —CF3, —CCl3, —CBr3, —CI3, —CN, —COR1A, —OR1A, —NR1AR1B, —C(O)OR1A, —C(O)NR1AR1B, —NO2, —SR1A, —S(O)n1R1A, —S(O)n1OR1A, —S(O)n1NR1AR1B, —NHNR1AR1B, —ONR1AR1B, —NHC(O)NHNR1AR1B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R4 is hydrogen, halogen, —N3, —CF3, —CCl3, —CBr3, —CI3, —CN, —COR4A, —OR4A, —NR4AR4B, —C(O)OR4A, —C(O)NR4AR4B, —NO2, —SR4A, S(O)n4R4A, —S(O)n4OR4A, —S(O)n4NR4AR4B, —NHNR4AR4B, —ONR4AR4B, —NHC(O)NHNR4AR4B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R5 is independently hydrogen, halogen, —N3, —CF3, —CCl3, —CBr3, —CI3, —CN, —COR5A, —OR5A, —NR5AR5B, —C(O)OR5A, —C(O)NR5AR5B, —NO2, —SR5A, —S(O)n5R5A, —S(O)n5OR5A, —S(O)n5NR5AR5B, —NHNR5AR5B, —ONR5AR5B, —NHC(O)NHNR5AR5B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, wherein
R5 and R6 are optionally combined to form a substituted or unsubstituted cycloalkyl;

R6 is unsubstituted C1-C6 alkyl;

R8 is hydrogen, halogen, —N3, —CF3, —CCl3, —CBr3, —CI3, —CN, —COR8A, —OR8A, —NR8AR8B, —C(O)OR8A, —C(O)NR8AR8B, —NO2, —SR8A, —S(O)n8R8A, —S(O)n8OR8A, —S(O)n8NR8AR8B, —NHNR8AR8B, —ONR8AR8B, —NHC(O)NHNR8AR8B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R9 is hydrogen, halogen, —N3, —CF3, —CCl3, —CBr3, —CI3, —CN, —COR9A, —OR9A, —NR9AR9B, —C(O)OR9A, —C(O)NR9AR9B, —NO2, —SR9A, —S(O)n9R9A, —S(O)n9OR9A, —S(O)n9NR9AR9B, —NHNR9AR8B, —ONR9AR9B, —NHC(O)NHNR9AR9B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R10 is H, —CH3, —C2H5, —C3H7, —CH2C6H5;

R1A, R1B, R4A, R4B, R5A, R5B, R8A, R8B, R9A, and, R9B are independently hydrogen, oxo, halogen, —CF3, —CN, —OH, —NH2, —COOH, —CONH2, —NO2, —SH, —S(O)2Cl, —S(O)3H, —S(O)4H, —S(O)2NH2, —NHNH2, —ONH2, —NHC(O)NHNH2, —NHC(O)NH2, —NHS(O)2H, —NHC(O)H, —NHC(O)—OH, —NHOH, —OCF3, —OCHF2, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted
or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and

n1, n4, n5, n8, and n9 are independently 1, 2, or 3.
US Pat. No. 9,563,266

HAPTIC AUGMENTED AND VIRTUAL REALITY SYSTEM FOR SIMULATION OF SURGICAL PROCEDURES

IMMERSIVETOUCH, INC., We...

1. A haptic augmented and virtual reality system for performing simulated surgical procedures that include open surgery steps
and microsurgery steps, the system comprising:
A) an open surgery station comprising:
a first haptic device comprising a hand-held stylus and driven by haptics rendering logic, wherein the first haptic device
tracks a user's hand movements and provides force feedback to the user;

a first display system driven by graphics logic, wherein the first display system comprises a display screen and a head tracking
system, and provides a dynamic user-centered perspective of open surgical views of a portion of a virtual patient's anatomy
and at least a first virtual surgical instrument, wherein the virtual instrument is visually superimposed over the hand-held
stylus of the haptic device, permitting the user to see both the virtual instrument and the user's hands, and moves as the
stylus moves based on data received from the first haptic device; and

open surgery station logic that integrates the haptics rendering logic and the graphics logic and provides real-time simulation
of the open surgery steps of the surgical procedure, including updating the open surgical views in real time in response to
user operations performed with the first haptic device and according to the position and orientation of the user's head given
by the head tracking system; and

B) a microsurgery station comprising:
a second haptic device driven by haptics rendering logic, wherein the second haptic device tracks the user's hand movements
and provides force feedback to the user;

a second display system driven by graphics logic, wherein the second display system comprises a binocular surgical microscope
eyepiece and display screens configured to allow the user to acquire depth perception, and provides microsurgical views of
a portion of the virtual patient's anatomy and at least a second virtual surgical instrument whose position is simulated based
on data received from the second haptic device; and

microsurgery station logic that integrates the haptics rendering logic and the graphics logic and provides real-time simulation
of the microsurgery steps of the surgical procedure including updating the microsurgical surgical views in real time in response
to user operations performed with the second haptic device.

US Pat. No. 9,533,073

MICROVASCULAR STAMP FOR PATTERNING OF FUNCTIONAL NEOVESSELS

The Board of Trustees of ...

1. A method of inducing growth of new blood vessels in a tissue comprising contacting one or more microvascular stamps comprising
one or more types of cells encapsulated in a poly(ethylene glycol) (PEGDA) and methacrylic polymer cross-linked hydrogel with
the tissue, wherein the cross-linked hydrogel comprises microchannels, wherein the new blood vessels are localized within
the lumina of the microchannels, and wherein the one or more microvascular stamps induce growth of new blood vessels in the
tissue.

US Pat. No. 9,517,324

EXTENDABLE INTRAVENOUS CATHETER

The Board of Trustees of ...

1. An intravenous catheter comprising:
a hub;
a tip portion comprising an opening;
a proximal portion attached to the hub; and
an extendable portion disposed between the proximal portion and the tip portion, the extendable portion having a retracted
position and an extended position and comprising a wire incorporated therein and anchored to the hub, the wire comprising
a coiled portion,

wherein the extendable portion is configured to be extended from the retracted position to the extended position by an extender
tool and to retain the extended position after removal of the extender tool, the extender tool being insertable and removable
from the catheter and dimensioned for passing through the hub, the proximal portion, and the extendable portion but not through
the opening in the tip portion.

US Pat. No. 9,488,545

HIGH SENSITIVITY ENVIRONMENTAL SENSOR NETWORK AND NETWORK SERVICES FOR STRUCTURAL HEALTH MONITORING

The Board of Trustees of ...

1. A high sensitivity structural health monitoring network, the network comprising:
a plurality of sensor nodes disposed apart from each other and communicating through one or more sensor channels, each sensor
node comprising a smart sensor circuit board, the sensor board comprising:

an interface to a wireless smart sensor board platform;
a multi-axis accelerometer having a sensitivity that can measure ambient structural vibrations resulting from non-catastrophic
routine environmental factors;

an analog to digital converter (ADC) for converting signals from the multi-axis accelerometer, the ADC having a plurality
of individual channels, each channel including being individually programmable for signal conditioning for providing data
to said interface;

a network framework providing network services for the plurality of sensor nodes through the one or more sensor channels,
the network framework including a time synchronization service with network-wide global timestamps for sensor data and a unified
sensing service that supports collection of data for all sensor channels from all nodes together with a single set of associated
time stamps.

US Pat. No. 9,484,745

VIRTUAL OSCILLATOR CONTROL OF POWER ELECTRONICS INVERTERS

RUTGERS, THE STATE UNIVER...

1. A system, comprising:
an oscillator controller, the oscillator controller including a resistor, a capacitor, an inductor, and a piecewise linear
voltage-dependent current source connected in parallel; and

power electronics inverters connected with the oscillator controller in a network, the oscillator controller to generate an
oscillating signal to modulate the power electronics inverters;

wherein the power electronics inverters utilize measurements at local terminals, without a need to exchange information between
other power electronics inverters for synchronization.

US Pat. No. 9,399,145

NANOSCALE NEUROMODULATING PLATFORM FOR RETINA NEURON ACTIVATION APPARATUS AND METHOD

The Board of Trustees of ...

1. A compound of formula:

and pharmaceutically acceptable salts thereof, wherein
R1 and R2 are independently C1-C12 alkyl, halo(C1-C12 alkyl), C2-C12 alkenyl, or C2-C12 alkynyl, each optionally substituted with 1, 2, 3 or 4 substituents selected from halogen, —CN, —NO2, —OR6, —NR62, —CO2R6, —CONR62, C3-C8 cycloalkyl, C3-C8 cycloalkenyl, aryl, heteroaryl, and heterocycle, wherein each cycloalkyl, cycloalkenyl, aryl, heteroaryl, and heterocycle
is optionally substituted with 1, 2, 3 or 4 R7;

R3 is hydrogen, C1-C6 alkyl, or halo(C1-C6 alkyl);

R4 and R5 are independently halogen, —CN, —NO2, C1-C6 alkyl, halo(C1-C6 alkyl), —OR6, —NR62, —CO2R6, or —CONR62;

X is —N(R8)—, —N(R8)CH2—, —N(R8)CHR8—, —N(R8)(CHR8)2-5—, or —O—;

Y?Z is —N?N— or —C(R8)?C(R8)—; and

R9 is hydrogen, —CHR6a, —OR6a, —NR6a2, —CO2R6a, —CONR6a2, —CON(R8)—(CH2)1-6—NR6a2, —N(R8)CO—(CH2)1-6—NR6a2, —CON(R8)—(CH2)1-6—N(R8)COR6a, —N(R8)CO—(CH2)1-6—N(R8)COR6a, —CON(R8)—(CH2)1-6—N(R8)COR10, or —N(R8)CO—(CH2)1-6—N(R8)COR10, wherein R10 is —CH2CH2(OCH2CH2)2-50—N(R8)COR6a;

where each R6 independently is hydrogen, C1-C6 alkyl, halo(C1-C6 alkyl), C3-C8 cycloalkyl, aryl, heteroaryl, heterocycle, aryl(C1-C6 alkyl)-, C3-C8cycloalkyl(C1-C6 alkyl)-, aryl(C1-C6 alkyl)-, heteroaryl(C1-C6 alkyl)-, or heterocycle(C1-C6 alkyl)-, wherein each alkyl, cycloalkyl, aryl, heteroaryl, and heterocycle is optionally substituted with 1, 2, 3 or 4 R7, or two R6 with the nitrogen to which they are attached form a heterocycle optionally substituted with 1, 2, 3 or 4 R7;

where each R6a independently is hydrogen, C1-C6 alkyl, halo(C1-C6 alkyl), C3-C8 cycloalkyl, aryl, heteroaryl, heterocycle, aryl(C1-C6 alkyl)-, C3-C8cycloalkyl(C1-C6 alkyl)-, aryl(C1-C6 alkyl)-, heteroaryl(C1-C6 alkyl)-, or heterocycle(C1-C6 alkyl)-, wherein each alkyl, cycloalkyl, aryl, heteroaryl, and heterocycle is optionally substituted with 1, 2, 3 or 4 R7, or two R6 with the nitrogen to which they are attached form a heterocycle optionally substituted with 1, 2, 3 or 4 R7;

where each R7 independently is halogen, —CN, —NO2, —N3, C1-C6 alkyl, halo(C1-C6 alkyl), C1-C6 alkoxy, amino, C1-C6alkylamino, diC1-C6alkylamino, —CO2H, —COH, —CO2R8, or —CON(R8)2; and

where each R8 independently is hydrogen or C1-C6 alkyl.

US Pat. No. 9,358,234

MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF

The Board of Trustees of ...

1. A method for treating a human patient having a neurological deficit, the neurological deficit being a spinal cord injury,
the method comprising the step of: (a) administering a pharmaceutically effective amount of more developmentally potent human
cells to the human patient; wherein the more developmentally potent human cells are obtained by contacting human mesenchymal
stem cells with an effective amount of BrdU for an effective period, wherein the BrdU-contacted, human mesenchymal stem cells
become more developmentally potent human cells capable of migrating to an area of tissue damage, and functioning in a manner
that reduces the neurological deficit, wherein the more developmentally potent cells are implanted into a body cavity that
is fluidly-connected to the area of neurological deficit.

US Pat. No. 9,238,309

METHODS FOR FABRICATING MICROSTRUCTURES

THE BOARD OF TRUSTEES OF ...

1. A method of making a microstructured object, the method comprising the steps of:
providing a semiconductor wafer;
patterning the semiconductor wafer with a preselected pattern of microfeatures;
molding an uncured first polymer to the patterned semiconductor wafer;
curing the first polymer, thereby forming a microstructured flexible polymer having the preselected pattern of microfeatures
on a surface of the microstructured flexible polymer;

removing the microstructured flexible polymer from the patterned semiconductor wafer;
providing a macro mold having one or more macro scale features, wherein the macro scale feature of the macro mold is one of
a recessed feature and a relief feature;

deforming at least a portion of the microstructured flexible polymer so as to conform the microstructured flexible polymer
to at least a portion of the surface of the one or more macro scale features of the macro mold wherein the microstructured
flexible polymer is placed so that a surface of the microstructured flexible polymer opposite to the surface having the preselected
pattern of microfeatures faces the portion of the surface of the one or more macro scale features of the macro mold;

providing a large-area prototype having one or more macro scale features, wherein the macro scale feature of the large-area
prototype is the other of a recessed feature and a relief feature;

depositing an uncured second polymer onto at least a portion of a surface of the one or more macro scale features of the prototype;
molding the uncured second polymer by bringing the macro mold and microstructured flexible polymer into contact with the prototype
and the uncured second polymer;

curing the uncured second polymer, thereby making a microstructured second polymer having the preselected pattern of microfeatures;
releasing the macro mold and microstructured flexible polymer from the prototype and microstructured second polymer; and
casting or molding a material to the prototype and microstructured second polymer, thereby replicating the preselected pattern
of microfeatures in at least a portion of a cast or molded object.

US Pat. No. 9,612,307

REDUCING ARTIFACTS IN MAGNETIC RESONANCE IMAGES ACQUIRED USING PROPELLER ECHO PLANAR IMAGING

THE BOARD OF TRUSTEES OF ...

1. A method comprising:
acquiring a first reference scan of an object in a magnetic resonance imaging system, wherein acquiring the first reference
scan comprises applying a first reference readout gradient along a first axis;

based on the first reference scan, determining a constant phase error cx associated with the first axis and a linear phase error lx along the first axis;

acquiring a second reference scan of the object, wherein acquiring the second reference scan comprises applying a second reference
readout gradient along a second axis, the second axis being orthogonal to the first axis;

based on the second reference scan, determining a constant phase error cy associated with the second axis and a linear phase error ly along the second axis;

acquiring a third reference scan of the object, wherein acquiring the third reference scan comprises applying a third reference
readout gradient along a third axis, the third axis being orthogonal to the first axis and the second axis;

based on the third reference scan, determining a constant phase error cz associated with the third axis and a linear phase error lz along the third axis;

acquiring a plurality of intersecting blades around a center of k-space, the plurality of intersecting blades being in an
imaging plane of k-space, wherein:

each of the plurality of intersecting blades is offset from the first axis by a respective blade angle ?, and
the imaging plane is defined by a rotation matrix A given by:

for each of the plurality of intersecting blades, determining a constant phase error c?, a linear phase error l?, and an oblique phase error o?, wherein:

the constant phase error c? is given by:

c?=(a0cos?+a1sin?)cx+(a3cos?+a4sin?)cy+(a6cos?+a7sin?)cz;

the linear phase error l? is given by:

l?=(a0cos?+a1sin?)2lx+(a3cos?+a4sin?)2ly+(a6cos?+a7sin?)2lz;

the oblique phase error is given by:

FOVro is a field of view of an applied blade readout gradient,

FOVpe is a field of view of an applied phase-encoding gradient,

Npe is a number of lines in a direction of the phase-encoding gradient, and

Nro is a number of samplings in a direction of the applied blade readout gradient along the number Npe of lines; and

displaying an image, wherein the image is generated based on at least one of the constant phase error c?, the linear phase error l?, and the oblique phase error o?,

wherein the method further comprises correcting the constant phase error c? and the linear phase error l? for each of the plurality of intersecting blades,

and wherein correcting the constant phase error c? and the linear phase error l? for each of the plurality of intersecting blades comprises:

applying a one-dimensional inverse Fourier transform in the direction of the blade readout gradient to produce hybrid time—k-space
data P?(x, ky);

for each sampling n in the Nro of samplings, determining a hybrid time—k-space constant and linear phase-corrected sampling Q?(xn, ky) given by:

Q?(xn,ky)=P?(xn,ky)ei(c?+nl?); and
applying a one-dimensional Fourier transform in the direction of the blade readout gradient to produce a k-space constant
and linear phase-corrected blade q?(kx, ky).

US Pat. No. 9,608,738

SYSTEM AND METHOD FOR BROADBAND DOPPLER COMPENSATION

THE BOARD OF TRUSTEES OF ...

1. A Doppler compensation system, comprising:
a transmitter unit for transmitting a signal, wherein the transmitted signal being associated with an emission time-scale;
a receiving unit for receiving a signal, wherein the received signal is associated with a receive time-scale that is not equivalent
to the emission time-scale; and

a Doppler compensating unit configured to estimate an inverse temporal distortion function, wherein the inverse temporal distortion
function is continuously estimated as a function of time on a recursive, sample-by-sample basis and is used to estimate the
transmitted signal, wherein the inverse temporal distortion function utilizes an adjusted sampling rate.

US Pat. No. 9,579,624

GAS REACTOR DEVICES WITH MICROPLASMA ARRAYS ENCAPSULATED IN DEFECT FREE OXIDE

The Board of Trustees of ...

1. A gas reactor device, comprising:
a plurality of microcavities or microchannels defined at least partially within a thick metal oxide layer consisting essentially
of defect free oxide being essentially free of microcracking, wherein said thick metal oxide layer is at least tens of microns
thick;

electrodes arranged with respect to said plurality of microcavities or microchannels to stimulate plasma generation in said
plurality of microcavities or microchannels upon application of suitable voltage wherein at least one of said electrodes is
encapsulated within said thick metal oxide layer;

a gas inlet to receive feedstock gas into said plurality of microcavities or microchannels; and
an outlet to outlet reactor product from said plurality of microcavities or microchannels.

US Pat. No. 9,555,644

NON-CONTACT TRANSFER PRINTING

THE BOARD OF TRUSTEES OF ...

1. A method of transferring ink from a donor substrate to a receiving substrate, said method comprising:
providing a transfer device having a transfer surface;
providing said donor substrate having a donor surface, said donor surface having said ink thereon, wherein said ink is a micro-sized
or nano-sized prefabricated electronic, optical or electro-optical device or component thereof;

contacting at least a portion of said transfer surface with at least a portion of said ink; separating said transfer surface
from said donor surface, wherein said ink is transferred from said donor surface to said transfer surface; positioning said
transfer surface having said ink disposed thereon into alignment with a receiving surface of said receiving substrate, wherein
a gap remains between said ink disposed on said transfer surface and said receiving surface; and actuating said transfer device,
said ink, or both of said transfer device and said ink by generating a force that releases said ink from said transfer surface
while maintaining at least a portion of said gap, thereby transferring said ink to said receiving surface and retaining the
structure of the ink.

US Pat. No. 9,478,942

TRANSISTOR LASER OPTICAL SWITCHING AND MEMORY TECHNIQUES AND DEVICES

The Board of Trustees of ...

1. A ring cavity light-emitting transistor device, comprising:
a planar semiconductor structure of a semiconductor base layer of a first conductivity type between semiconductor collector
and emitter layers of a second conductivity type;

base, collector, and emitter metalizations respectively coupled with said base layer, said collector layer, and said emitter
layer, said base metallization comprising at least one annular ring coupled with a surface of said base layer; and

an annular ring-shaped optical resonator in a region of said semiconductor structure generally including the interface of
the base and emitter layers;

whereby application of electrical signals with respect to said base, collector, and emitter metalizations causes light emission
in said base layer that propagates in said ring-shaped optical resonator cavity.

US Pat. No. 10,072,046

NON-NATURALLY OCCURRING PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND METHODS OF USING

NUtech Ventures, Lincoln...

1. A porcine reproductive and respiratory syndrome virus (PRRSV)-CON nucleic acid having the sequence shown in SEQ ID NO: 1.

US Pat. No. 9,986,924

IMPLANTABLE BIOMEDICAL DEVICES ON BIORESORBABLE SUBSTRATES

The Board of Trustees of ...

1. An implantable biomedical device for actuating a target tissue or sensing a parameter associated with the target tissue in a biological environment, said device comprising:a bioresorbable substrate;
an electronic device comprising one or more metallic conductor components including at least one electrode supported by said bioresorbable substrate, wherein at least one of said metallic conductor components has at least one physical dimension less than or equal to 100 microns;
a barrier layer encapsulating at least a portion of said metallic conductor components; and
a transmitter or a receiver operationally connected to said one or more metallic conductor components;wherein said bioresorbable substrate, said electronic device, and said barrier layer provide a net bending stiffness of the implantable biomedical device of less than 1×109 GPa ?m4; and wherein upon contact with said biological environment said bioresorbable substrate is at least partially resorbed, and the Young's modulus of the implantable biomedical device decreases by at least 20% upon complete or partial resorption of the bioresorbable substrate, thereby establishing an interface providing for conformal contact between said electronic device and said target tissue.

US Pat. No. 9,654,765

SYSTEM FOR EXECUTING 3D PROPAGATION FOR DEPTH IMAGE-BASED RENDERING

THE BOARD OF TRUSTEES OF ...

1. A method for executing depth image-based rendering of a 3D image from one or more color cameras and at least one depth
camera by at least one computer having a processor and memory, the method comprising:
propagating, using the at least one computer, depth information from the at least one depth camera to an image plane of each
color camera to produce a propagated depth image for each color camera;

enhancing, using the at least one computer, the propagated depth image for each color camera with the color and propagated
depth information thereof to produce an enhanced depth image for each color camera, wherein, for the propagated depth image
for each color camera, the enhancing comprises (i) depth-color bilateral filtering (DCBF) and (ii) filling holes along a specific
direction that is determined based on a line originating from an epipole; and

creating, using the at least one computer, a complete image from the one or more enhanced depth images.

US Pat. No. 9,663,482

SUBSTITUTED PIPERAZINYL ACETOHYDRAZIDE PROCASPASE-ACTIVATING COMPOUNDS

The Board of Trustees of ...

17. A method of treating a cancer in a patient in need thereof comprising administering an effective anti-cancer amount of
a compound of claim 1 to the patient, wherein the cancer is lymphoma and the cancer is thereby treated.

US Pat. No. 9,608,848

COMMUNICATING THROUGH PHYSICAL VIBRATION

The Board of Trustees of ...

1. A data transmitter comprising:
a set of vibration motors comprising a first vibration motor to generate first symbols along a first axis at a first frequency
and a second vibration motor to generate second symbols along a second axis at a second frequency, the first axis being substantially
orthogonal to the second axis;

a switch coupled to the set of vibration motors, the switch to regulate voltage from a direct-current (DC) power supply to
the set of vibration motors; and

a microcontroller coupled to the switch, the microcontroller to generate a pulse width modulation (PWM) signal with which
to drive the switch and regulate the voltage to the set of vibration motors in a sinusoidal manner, to generate data as the
first symbols and the second symbols from vibrations that form a series of bits from the set of vibration motors.

US Pat. No. 9,605,104

ANTIOXIDANT TREATMENT OF ASPHALT BINDERS

The Board of Trustees of ...

1. A modified asphalt binder composition made by the process comprising mixing an asphalt binder, an antioxidant composition,
and an acidic catalyst to create a modified asphalt binder characterized by an aging index that is lower than that of an unmodified
asphalt binder;
wherein the antioxidant composition comprises an aldehyde comprising furfural in an amount of about 2 wt % and a thioester
comprising dilauryl thiodipropionate in an amount of about 1.5 wt %, each based on the weight of the asphalt binder; wherein
the thioester and the aldehyde are present in an effective amount capable of decreasing an aging index based on a rutting
parameter at 64° C., decreasing a fatigue parameter at 25° C. and decreasing a stiffness at ?12° C., each parameter measured
in accordance with SUPERPAVE, of an asphalt compared to the asphalt without the thioester or the aldehyde.

US Pat. No. 9,592,229

POTENT ANTICANCER ACTIVITY VIA DUAL COMPOUND ACTIVATION

The Board of Trustees of ...

1. A composition comprising (a) a compound of Formula (I):
wherein R is H or Me;
(b) the compound PAC-1:
and (c) a pharmaceutically acceptable diluent, excipient, or carrier.

US Pat. No. 9,583,939

OPTIMIZING SOLAR POWER CONVERSION

THE BOARD OF TRUSTEES OF ...

1. A method for maximizing power generation in a solar power system, which includes a set of n series-connected solar power
units and a set of n?1 DC-DC converting units, each of the n solar power units generates a DC photovoltaic current and produces
a DC photovoltaic voltage, and each of n?1 DC-DC converting units is coupled to and controls at least one of the n solar power
units, the method comprising:
monitoring and comparing the n currents generated by the n solar power units;based on the current comparison, determining a series current for the n solar power units;
controlling the n solar power units, via the correspondingly coupled n?1 DC-DC converting units, so that each of the generated
photovoltaic currents is substantially equal to the determined series current;

determining whether one of the n solar power units generates a current that is less than a predetermined current threshold
percentage of the determined series current; and

based on the current threshold percentage determination, causing the correspondingly coupled DC-DC converting unit to shunt
the one of the n solar power units.